Other and unspecified effects of external causes

ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T66-T78 Cause of death: ICD-10 — T66-T78 2 out of 7 registries used, show all original rules.	15463
4. Check minimum number of events None	15463
5. Include endpoints ST19_UNSPE_EFFEC_RADIATION ST19_EFFEC_HEAT_LIGHT ST19_HYPOTHERMIA ST19_OTHER_EFFEC_REDUCED_TEMPE ST19_EFFEC_AIR_PRESSURE_WATER_PRESSURE ST19_ASPHYXIATION ST19_EFFEC_OTHER_DEPRI ST19_MALTR_SYNDR ST19_EFFEC_OTHER_EXTER_CAUSES ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED	15463
6. Filter based on genotype QC (FinnGen only)	13859

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S|T
Name in latin: Effectus causarum externarum aliarum sive non specificatarum

NAME	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	ST19_UNSPE_EFFEC_RADIATION\|ST19_EFFEC_HEAT_LIGHT\|ST19_HYPOTHERMIA\|ST19_OTHER_EFFEC_REDUCED_TEMPE\|ST19_EFFEC_AIR_PRESSURE_WATER_PRESSURE\|ST19_ASPHYXIATION\|ST19_EFFEC_OTHER_DEPRI\|ST19_MALTR_SYNDR\|ST19_EFFEC_OTHER_EXTER_CAUSES\|ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T6[6-9]\|T7[0-8]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T6[6-9]\|T7[0-8]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified effects of external causes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13859	8819	5040
Unadjusted period prevalence (%)	2.83	3.13	2.31
Median age at first event (years)	45.80	43.43	49.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14583: Matched controls
145812

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.2

322.6

1397

4673

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

318.4

3292

16875

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

316.1

1930

7793

S06.0

ICD-10 Finland

Concussion

2.6

314.0

2170

9311

R03AC02

ATC

salbutamol; inhalant

1.9

312.1

8806

64199

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

311.7

6609

43855

L50.8

ICD-10 Finland

Other urticaria

6.4

307.7

623

1006

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

16.9

307.7

1369

888

T74.1

ICD-10 Finland

Physical abuse

35.8

307.7

2304

760

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

307.7

6378

41241

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

106.4

307.7

189

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

253.8

307.7

347

A92

ICPC

Allergy/allergic reaction NOS

4.3

307.7

1046

2569

T78.3

ICD-10 Finland

Angioneurotic oedema

179.0

307.7

2205

145

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.1

307.7

2696

7635

T78.4

ICD-10 Finland

Allergy, unspecified

66.5

307.7

6760

1871

L50.0

ICD-10 Finland

Allergic urticaria

5.7

307.7

944

1747

H02AB06

ATC

prednisolone; systemic

2.9

307.7

8543

47816

X57

ICD-10 Finland

Unspecified privation

8.5

307.7

920

1140

W86

ICD-10 Finland

Exposure to other specified electric current

23.2

307.7

460

204

W84

ICD-10 Finland

Unspecified threat to breathing

62.3

307.7

287

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

32.0

307.7

788

260

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.0

307.7

990

2114

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.5

307.7

573

789

XQ800

NOMESCO Finland

Prick test

5.5

307.7

2782

6031

T75.4

ICD-10 Finland

Effects of electric current

73.3

307.7

1024

150

X58

ICD-10 Finland

Exposure to other specified factors

2.9

307.7

3457

14216

L50.9

ICD-10 Finland

Urticaria, unspecified

4.5

307.7

1225

2916

X59

ICD-10 Finland

Exposure to unspecified factor

3.6

307.7

4808

17527

C01CA24

ATC

epinephrine; parenteral

14.8

307.7

4523

4295

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

289.5

307.7

2000

T68

ICD-10 Finland

Hypothermia

637.5

307.7

727

R06AE07

ATC

cetirizine; oral

2.4

307.7

8131

50397

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

9.1

302.0

371

415

R06AX27

ATC

desloratadine; oral

2.0

301.9

5359

33416

AA1AD

NOMESCO Finland

CT of head and brain

2.1

297.0

3989

22529

N02AX02

ATC

tramadol; systemic, rectal

1.9

286.8

6158

40698

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

279.7

1055

3233

R06.0

ICD-10 Finland

Dyspnoea

2.0

271.9

4020

23375

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

13.4

264.4

250

190

R51.80

ICD-10 Finland

Headache

2.1

261.9

3074

16409

N05AH04

ATC

quetiapine; oral

2.1

257.7

3250

17806

X31

ICD-10 Finland

Exposure to excessive natural cold

27.5

256.6

174

H02AB07

ATC

prednisone; oral

2.4

252.5

2092

9684

T74.2

ICD-10 Finland

Sexual abuse

43.7

240.7

143

N05BA04

ATC

oxazepam; oral

1.9

239.0

4109

24951

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.6

238.1

831

2417

Y09

ICD-10 Finland

Assault by unspecified means

11.5

237.2

247

219

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

235.7

2626

13685

R06AE09

ATC

levocetirizine; oral

2.1

233.6

2614

13640

N03AX16

ATC

[U] pregabalin

2.0

228.1

3285

18759

Z3231

NOMESCO Finland

Registered nurse

1.9

227.2

4059

24884

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

227.1

3948

23991

M79.6

ICD-10 Finland

Pain in limb

1.7

226.5

6750

48150

R03DC03

ATC

montelukast; oral

2.0

226.0

2862

15614

A02BC02

ATC

pantoprazole; systemic

1.8

224.3

9527

75005

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

222.8

4401

27807

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

17.4

222.1

182

106

J01FF01

ATC

clindamycin; systemic

1.9

221.8

4048

24949

Y96.9

ICD-10 Finland

Unspecified type of accident

5.0

217.0

481

995

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

216.4

4258

26826

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

214.8

3961

24449

N06AX11

ATC

mirtazapine; oral

1.8

211.9

5153

34516

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

207.4

2986

16979

R02

ICPC

Shortness of breath/dyspnoea

2.1

205.5

2156

10930

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

203.6

2022

10030

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.4

199.8

514

1200

X27

ICD-10 Finland

Contact with other specified venomous animals

29.8

196.9

130

N05BA01

ATC

diazepam; systemic, rectal

2.2

196.9

1926

9488

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

196.7

3046

17708

Y07

ICD-10 Finland

Other maltreatment

7.7

194.9

275

364

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

194.3

3308

19817

R60.0

ICD-10 Finland

Localized oedema

2.2

189.5

1825

8925

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

3.2

187.1

784

2551

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

8.4

186.7

243

292

M54.5

ICD-10 Finland

Low back pain

1.7

185.5

5689

40217

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

182.9

2843

16502

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

180.8

2045

10628

Z51.6

ICD-10 Finland

Desensitization to allergens

4.9

180.0

399

825

N06AB04

ATC

citalopram; systemic

1.9

177.2

3018

18013

T67.0

ICD-10 Finland

Heatstroke and sunstroke

61.7

176.7

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

175.2

2255

12265

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

175.2

2873

16937

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

6.3

174.6

294

471

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.9

173.8

393

826

R42

ICD-10 Finland

Dizziness and giddiness

1.8

172.9

3187

19471

T70.0

ICD-10 Finland

Otitic barotrauma

18.9

171.6

135

N02BE01

ATC

paracetamol; systemic, rectal

2.0

170.3

12809

113652

Y34

ICD-10 Finland

Unspecified event, undetermined intent

8.5

168.5

218

260

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.3

167.2

1358

6173

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

166.9

2233

12292

R06AX22

ATC

ebastine; oral

1.9

165.8

2738

16146

R53

ICD-10 Finland

Malaise and fatigue

1.7

164.2

3942

25920

N06AX16

ATC

venlafaxine; oral

1.9

163.3

2418

13762

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.4

163.2

329

626

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

162.9

1319

5985

R03BA02

ATC

budesonide; inhalant

1.8

161.3

2761

16448

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

159.8

6081

44877

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

5.6

157.6

301

545

J01DB01

ATC

cefalexin; oral

1.8

157.4

12103

106067

XQ802

NOMESCO Finland

Epicutan test

2.9

156.7

801

2912

XQ820

NOMESCO Finland

Exposure to medicinal substance

10.0

156.1

178

180

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.1

154.9

431

1067

P15

ICPC

Chronic alcohol abuse

3.2

154.6

622

1972

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

153.0

6266

46900

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

151.7

2767

16769

N06AX21

ATC

duloxetine; oral

2.0

150.7

1905

10256

R03BA05

ATC

fluticasone; inhalant

1.8

150.6

2825

17259

Y04.2

ICD-10 Finland

Assault by bodily force by friend

12.1

149.8

150

125

N05CF01

ATC

zopiclone; oral

1.7

149.6

4049

27357

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

149.2

4185

28533

N03AX12

ATC

[U] gabapentin; oral

1.9

148.2

2205

12533

P01AB01

ATC

metronidazole; oral, rectal

1.6

147.5

5654

41564

G44.2

ICD-10 Finland

Tension-type headache

1.9

147.3

2283

13146

Z71.8

ICD-10 Finland

Other specified counselling

1.6

147.3

5380

39098

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

147.1

795

2975

J01AA02

ATC

doxycycline; systemic

1.6

146.3

10496

89076

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.4

145.2

373

869

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

11.4

144.9

151

134

E0000UV, ,

ATC

1.6

144.2

6194

46669

N07BB01

ATC

disulfiram; oral

2.8

143.0

754

2785

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

142.3

1603

8272

J01MA02

ATC

ciprofloxacin; systemic

1.6

141.8

4915

35198

R06AX13

ATC

loratadine; oral

1.8

141.4

2437

14487

J01MA12

ATC

levofloxacin; systemic

1.8

141.4

2324

13616

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.7

141.1

457

1260

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

138.7

1286

6156

H02AB04

ATC

methylprednisolone; systemic

1.9

138.5

1981

11096

S18

ICPC

Laceration/cut

1.6

138.2

6229

47293

X39

ICD-10 Finland

Exposure to other and unspecified forces of nature

22.9

137.8

100

A01

ICPC

Pain general/multiple sites

2.1

137.5

1538

7910

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

135.2

3179

20610

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

135.0

1614

8501

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

15.2

134.8

118

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

133.7

3263

21355

L50.3

ICD-10 Finland

Dermatographic urticaria

3.8

133.1

409

1087

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.9

132.8

664

2383

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.5

131.4

458

1326

N03AX09

ATC

lamotrigine; oral

2.4

131.1

967

4200

M25.5

ICD-10 Finland

Pain in joint

1.6

130.6

4872

35325

A02BC05

ATC

esomeprazole; systemic

1.6

130.4

5323

39385

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

130.3

2025

11632

L20.0

ICD-10 Finland

Besnier prurigo

2.0

130.2

1508

7847

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

130.1

1642

8806

C07AB07

ATC

bisoprolol; oral

1.6

130.0

5388

39991

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

129.8

1996

11427

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

129.7

3205

21021

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

128.7

857

3552

XQ801

NOMESCO Finland

Intracutantest

8.0

128.6

175

222

M03BX02

ATC

tizanidine; oral

1.5

128.5

8716

71827

W19

ICD-10 Finland

Unspecified fall

2.0

128.3

1480

7688

J45

ICD-10 Finland

Asthma

1.9

128.1

1681

9135

T75.1

ICD-10 Finland

Drowning and nonfatal submersion

1249.6

127.3

124

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

126.8

1969

11302

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

126.5

6838

53640

R96

ICPC

Asthma

2.0

126.3

1501

7878

L03

ICPC

Low back symptom/complaint

1.6

126.1

4368

31081

N06AB10

ATC

escitalopram; oral

1.6

126.0

3392

22716

N05AH03

ATC

olanzapine; systemic

2.2

125.3

1110

5210

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

124.3

8473

69658

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.7

123.7

395

1078

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

123.5

1915

10979

R11

ICD-10 Finland

Nausea and vomiting

2.0

122.9

1433

7467

C07AA05

ATC

propranolol; systemic

1.7

122.7

3043

19939

P01

ICPC

Feeling anxious/nervous/tense

1.7

120.5

2631

16656

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

120.5

2192

13182

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

119.4

1289

6528

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

118.7

2003

11777

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

118.4

2039

12061

N03AG01

ATC

valproic acid; systemic, rectal

2.3

118.4

965

4373

F10.24

ICD-10 Finland

Alcohol depence active use

4.1

117.3

323

793

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

117.2

1886

10927

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

116.7

3231

21725

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

116.2

3180

21318

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

116.1

4521

32895

R06.4

ICD-10 Finland

Hyperventilation

3.9

115.9

344

892

P29

ICPC

Psychological sympt/compl other

1.9

115.4

1529

8319

L17

ICPC

Foot/toe symptom/complaint

1.6

115.4

4264

30659

Y98

ICD-10 Finland

Lifestyle-related condition

11.8

115.0

117

100

SPAT1254

SPAT

Administration of medicine

1.8

114.6

2054

12285

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

114.5

2884

18927

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

113.9

1951

11510

D11

ICPC

Diarrhoea

1.8

113.8

2081

12517

T73.3

ICD-10 Finland

Exhaustion due to excessive exertion

25.6

113.6

R05

ICPC

Cough

1.6

113.5

3707

25899

N03AE01

ATC

clonazepam; systemic

2.4

113.0

833

3612

J46

ICD-10 Finland

Status asthmaticus

3.0

112.4

504

1701

N06AB06

ATC

sertraline; oral

1.8

112.4

1881

11019

R4110

NOMESCO Finland

Physiotherapy

1.6

110.6

3587

24993

R01AD09

ATC

mometasone; nasal

1.5

110.6

6629

52574

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

110.3

6063

47261

J01DA01

ATC

[U] cefalexin

1.5

109.7

8358

69431

M79.1

ICD-10 Finland

Myalgia

1.7

109.4

2328

14596

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

109.1

1756

10159

R50.9

ICD-10 Finland

Fever, unspecified

1.7

108.7

2242

13937

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

108.4

1072

5246

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

14.4

107.3

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

107.1

867

3914

A03

ICPC

Fever

1.6

107.0

2987

20064

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

107.0

10552

92098

Z3226

NOMESCO Finland

Physiotherapist

1.7

106.8

2345

14818

R03AC03

ATC

terbutaline; inhalant

1.8

106.7

1980

11941

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

106.2

7894

65074

R55

ICD-10 Finland

Syncope and collapse

1.9

106.1

1396

7567

W69

ICD-10 Finland

Drowning and submersion while in natural water

30.1

104.8

R52.9

ICD-10 Finland

Pain, unspecified

1.9

104.7

1561

8810

XQ899

NOMESCO Finland

Other assessment of skin

8.0

104.4

142

180

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

104.0

716

3008

J01FA06

ATC

roxithromycin; oral

1.5

103.8

5058

38350

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

103.8

626

2471

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

103.4

3447

24110

R01AD08

ATC

fluticasone; nasal

1.5

103.1

4067

29511

D07AA02

ATC

hydrocortisone; topical

1.7

102.7

2186

13685

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

102.7

1239

6517

L12

ICPC

Hand/finger symptom/complaint

1.6

102.3

2615

17166

T78.9

ICD-10 Finland

Adverse effect, unspecified

155.4

102.3

108

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

102.2

1170

6041

J01FA10

ATC

azithromycin; systemic

1.5

101.9

8507

71431

L50.1

ICD-10 Finland

Idiopathic urticaria

5.4

101.7

202

379

S29

ICPC

Skin symptom/complaint other

1.6

101.6

2852

19153

R74

ICPC

Upper respiratory infection acute

1.5

101.1

5600

43484

L28

ICPC

Limited function/disability (L)

1.7

100.8

2154

13495

D01

ICPC

Abdominal pain/cramps general

1.7

100.4

2057

12737

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.4

100.4

740

3205

ZXE00

NOMESCO Finland

One hour or less

1.5

100.1

5118

39104

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.6

100.0

625

2509

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

99.8

784

3492

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

99.6

4028

29338

D07AC01

ATC

betamethasone; topical

1.5

98.8

4810

36375

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

98.6

1427

7971

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

98.4

4011

29251

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

98.2

1237

6599

C03CA01

ATC

furosemide; systemic

1.6

98.0

2817

19003

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

97.9

3072

21152

R03BB04

ATC

tiotropium bromide; inhalant

2.0

97.7

1107

5692

P19

ICPC

Drug abuse

4.1

96.8

266

652

N05AX12

ATC

aripiprazole; systemic

2.3

96.7

802

3654

A04

ICPC

Weakness/tiredness general

1.6

96.6

2376

15424

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

96.6

848

3955

Z00.8

ICD-10 Finland

Other general examinations

1.9

96.1

1257

6791

S80.0

ICD-10 Finland

Contusion of knee

1.9

96.0

1255

6778

M79.7

ICD-10 Finland

Fibromyalgia

2.5

95.5

610

2474

A46

ICD-10 Finland

Erysipelas

1.8

95.4

1725

10302

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.0

94.9

1083

5580

A02BC01

ATC

omeprazole; systemic

1.5

94.8

3368

23816

N05AA02

ATC

levomepromazine; systemic

2.6

94.8

583

2322

N05BA12

ATC

alprazolam; oral

1.9

94.7

1306

7178

T78.8

ICD-10 Finland

Other adverse effects, not elsewhere classified

197.3

94.4

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.1

94.4

265

660

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

94.1

3314

23384

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

94.1

1319

7287

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.1

94.0

931

4552

SPAT1240

SPAT

Therapeutic discussion

1.7

93.9

1814

11038

D07AB08

ATC

desonide; topical

1.8

93.8

1553

9035

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

93.8

1444

8217

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.4

93.5

647

2723

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

93.4

10695

94548

N01

ICPC

Headache

1.7

93.3

2103

13339

UJF32

NOMESCO Finland

Coloscopy

1.6

93.0

3022

20941

N05AX08

ATC

risperidone; systemic

2.0

92.5

1105

5784

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.7

92.3

294

801

R07.3

ICD-10 Finland

Other chest pain

1.8

92.2

1396

7901

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

92.2

1440

8229

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

89.7

1372

7787

WQ000

NOMESCO Finland

Hyposensibilisation

5.2

89.4

183

353

N06AB03

ATC

fluoxetine; oral

1.7

89.3

1681

10143

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.8

89.0

201

422

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

88.8

4311

32423

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

88.8

1006

5167

ZY010

NOMESCO Finland

Hospital outpatient

2.1

88.5

924

4605

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

88.3

332

1008

N02AA05

ATC

oxycodone; systemic

1.7

87.9

1902

11920

R00.2

ICD-10 Finland

Palpitations

1.9

87.6

1243

6888

H01

ICPC

Ear pain/earache

1.7

87.2

1971

12491

WX892

NOMESCO Finland

Monitored bed care

2.0

87.0

957

4862

Y96.8

ICD-10 Finland

Other type of accident

5.2

87.0

179

347

M01AB05

ATC

diclofenac; systemic, rectal

1.4

86.5

8660

74051

R21

ICPC

Throat symptom/complaint

1.5

86.5

3741

27472

Z00.0

ICD-10 Finland

General medical examination

1.6

86.5

2661

18174

Z2446

NOMESCO Finland

Social worker

2.0

86.2

998

5163

Y94.0

ICD-10 Finland

Accident at home

3.5

86.1

305

892

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.5

86.0

209

466

Z2221

NOMESCO Finland

Medical doctor

1.5

85.5

3607

26347

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

4.7

84.9

196

419

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

5.1

84.8

178

351

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

84.5

1137

6190

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

84.4

1183

6526

E000001, ,

ATC

1.5

84.2

2768

19175

T67.5

ICD-10 Finland

Heat exhaustion, unspecified

37.3

83.8

N30.0

ICD-10 Finland

Acute cystitis

1.6

83.7

2427

16335

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

83.6

774

3684

P03

ICPC

Feeling depressed

1.7

83.5

1870

11813

WX002

NOMESCO Finland

Sedation and analgesia

1.6

83.4

2215

14603

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

83.0

632

2774

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

83.0

1449

8548

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

82.5

1872

11863

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

82.5

1978

12712

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

82.3

3135

22397

A02BA02

ATC

ranitidine; systemic

1.6

82.2

2043

13248

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

82.1

4567

35124

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

81.8

1288

7366

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

81.7

644

2869

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.3

81.7

309

942

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

81.6

852

4245

S01.0

ICD-10 Finland

Open wound of scalp

2.0

81.5

992

5219

C08CA01

ATC

amlodipine; oral

1.5

80.7

3905

29238

R03BA01

ATC

beclometasone; inhalant

1.7

80.7

1771

11121

N05AF03

ATC

chlorprothixene; systemic

2.8

80.2

420

1542

N05BB01

ATC

hydroxyzine; systemic

2.0

79.6

893

4565

P76

ICPC

Depressive disorder

1.8

79.5

1201

6779

R52.2

ICD-10 Finland

Other chronic pain

2.4

79.0

567

2425

P16

ICPC

Acute alcohol abuse

3.3

78.8

308

958

J02AC01

ATC

fluconazole; systemic

1.4

78.7

5387

42895

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

78.7

2222

14843

A29

ICPC

General symptom/complaint other

1.7

78.6

1720

10788

K30

ICD-10 Finland

Functional dyspepsia

1.7

78.4

1602

9868

A02BC03

ATC

lansoprazole; oral

1.5

78.2

3211

23258

P74

ICPC

Anxiety disorder/anxiety state

2.0

78.2

885

4539

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.9

77.7

366

1269

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.4

77.1

278

822

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

76.6

3408

25066

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

76.4

472

1883

Z25

ICPC

Assault/harmful event problem

4.1

76.4

209

511

SPAT1263

SPAT

Sampling

1.4

76.0

5610

45169

ZXD05

NOMESCO Finland

Urgent procedure

1.4

75.9

3915

29600

Z72.2

ICD-10 Finland

Drug use

4.9

75.9

168

347

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

75.7

1070

5911

N05CD07

ATC

temazepam; oral

1.8

75.3

1134

6391

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

36.3

75.2

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.5

75.1

489

2000

EBA00

NOMESCO Finland

Extraction of tooth

1.4

75.0

5198

41382

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

74.5

7428

62736

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

74.5

1017

5557

N17

ICPC

Vertigo/dizziness

1.7

74.2

1608

10052

K02.1

ICD-10 Finland

Caries of dentine

1.4

73.9

8728

75708

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

73.7

2654

18682

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

73.3

2757

19580

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

73.3

728

3557

Y87.1

ICD-10 Finland

Sequelae of assault

17.9

73.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

73.1

1216

7062

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

73.0

1510

9322

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

72.6

907

4811

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

72.4

801

4072

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

72.2

1524

9456

SPAT1260

SPAT

Consultation of another employee

1.6

72.2

2210

15012

N05CF02

ATC

zolpidem; oral

1.6

71.9

2226

15155

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

71.6

1161

6689

M01AE02

ATC

naproxen; oral, rectal

1.4

71.5

7836

66987

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

71.2

896

4764

G47.3

ICD-10 Finland

Sleep apnoea

1.5

71.1

2798

20039

J01FA09

ATC

clarithromycin; systemic

1.4

71.0

4129

31824

P06

ICPC

Sleep disturbance

1.6

70.6

1960

13011

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

70.6

1228

7221

A11

ICPC

Chest pain NOS

1.8

70.4

1054

5925

R01AD58

ATC

fluticasone, combinations; nasal

1.4

70.3

3800

28899

N02BF02

ATC

pregabalin; oral

1.9

70.2

941

5108

J01MA14

ATC

moxifloxacin; systemic

1.8

70.1

1076

6095

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

69.8

1489

9259

SPAT1283

SPAT

Restricted health certificate

1.5

69.8

3016

21994

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

69.7

628

2954

D07AC13

ATC

mometasone; topical

1.4

69.7

3616

27291

Y94.8

ICD-10 Finland

Other leisure activity accident

2.5

69.6

434

1739

R01AD12

ATC

fluticasone furoate; nasal

1.4

69.5

4643

36614

N06AA09

ATC

amitriptyline; systemic

1.8

69.5

1047

5898

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

69.4

987

5460

R13

ICD-10 Finland

Dysphagia

1.9

69.2

853

4503

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

68.9

1914

12703

K08.80

ICD-10 Finland

Toothache NOS

1.7

68.9

1388

8500

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

68.9

648

3100

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

68.9

2991

21825

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

68.9

917

4966

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

6.0

68.8

122

206

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

68.6

482

2041

J01EA01

ATC

trimethoprim; systemic

1.5

68.5

3195

23629

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

68.4

650

3121

J30.3

ICD-10 Finland

Other allergic rhinitis

2.2

68.4

614

2884

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

68.0

835

4401

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.6

67.9

228

644

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.0

67.6

190

474

L01

ICPC

Neck symptom/complaint

1.5

67.6

2325

16176

J20

ICD-10 Finland

Acute bronchitis

1.7

67.5

1435

8913

D10

ICPC

Vomiting

1.8

67.5

1118

6479

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

67.5

1184

6977

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

67.3

683

3363

R06.2

ICD-10 Finland

Wheezing

2.1

67.2

669

3271

S22.3

ICD-10 Finland

Fracture of rib

1.9

67.2

882

4754

L02

ICPC

Back symptom/complaint

1.6

66.9

1578

10065

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.9

66.9

330

1174

SPAT1310

SPAT

Counselling related to known health issue

1.4

66.8

4098

31805

D06

ICPC

Abdominal pain localized other

1.7

66.6

1364

8386

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.4

66.6

240

710

N06AX12

ATC

bupropion; oral

1.7

66.2

1243

7464

WX290

NOMESCO Finland

Other blockage of nerve

1.3

66.0

7190

61077

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

66.0

642

3111

Y08.8

ICD-10 Finland

Assault by other specified means by other known person

16.7

65.9

P99

ICPC

Psychological disorders other

2.2

65.7

552

2523

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

65.0

1475

9313

J45.8

ICD-10 Finland

Mixed asthma

2.4

64.8

444

1859

M01AH05

ATC

etoricoxib; oral

1.3

64.6

8205

71223

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

64.5

3897

30129

K04.0

ICD-10 Finland

Pulpitis

1.7

64.3

1415

8862

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

64.0

1062

6154

L15

ICPC

Knee symptom/complaint

1.4

63.9

3219

24099

R03AC13

ATC

formoterol; inhalant

2.1

63.8

608

2923

A06AD11

ATC

lactulose; oral

1.6

63.6

1478

9385

S21

ICPC

Skin texture symptom/complaint

1.5

63.4

1961

13315

Z2445

NOMESCO Finland

Psychologist

2.1

63.3

667

3329

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

62.5

4137

32438

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.8

62.3

193

516

W64

ICD-10 Finland

Exposure to other and unspecified animate mechanical forces

4.2

61.9

165

396

WZC30

NOMESCO Finland

Teaching

1.5

61.8

1947

13270

SFA30

NOMESCO Finland

Three-surface restoration

1.3

61.3

5392

44181

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

61.2

984

5647

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

60.8

4084

32073

SPAT1301

SPAT

No procedures

1.4

60.8

3854

29981

A28

ICPC

Limited function/disability NOS

1.6

60.7

1665

10994

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

60.5

826

4506

M54.2

ICD-10 Finland

Cervicalgia

1.7

60.4

1114

6651

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

60.3

982

5655

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

60.3

492

2222

L16

ICPC

Ankle symptom/complaint

1.6

60.2

1714

11416

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

60.0

440

1899

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

60.0

706

3665

SGA01

NOMESCO Finland

Emergency treatment

1.5

60.0

2375

16965

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

59.7

495

2250

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

59.6

1275

7920

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

59.5

1596

10481

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

59.5

5164

42176

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

59.3

278

962

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

59.1

1112

6672

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

59.1

573

2771

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

59.1

465

2068

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

6.1

59.0

102

168

T67.1

ICD-10 Finland

Heat syncope

107.2

58.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

58.8

1737

11662

B01AB05

ATC

enoxaparin; parenteral

1.4

58.8

3477

26709

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.5

58.7

144

324

F61.0

ICD-10 Finland

Mixed personality disorders

2.8

58.6

304

1111

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

58.5

2190

15459

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

58.4

3968

31174

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.6

58.4

334

1283

N02BF01

ATC

gabapentin; oral

1.6

58.3

1310

8237

N05BA02

ATC

chlordiazepoxide; systemic

2.8

58.3

292

1047

H57.1

ICD-10 Finland

Ocular pain

2.0

58.2

624

3133

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

57.6

6225

52414

Z72.1

ICD-10 Finland

Alcohol use

3.3

57.6

219

670

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.8

57.6

294

1065

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

57.4

863

4851

SFA20

NOMESCO Finland

Two-surface restoration

1.3

57.4

8236

72171

N06AB05

ATC

paroxetine; oral

1.9

57.4

802

4407

A99

ICPC

Disease/condition unspecnature/site

1.6

57.3

1326

8400

R03BA08

ATC

ciclesonide; inhalant

1.7

57.2

1137

6923

R03AC12

ATC

salmeterol; inhalant

2.2

57.2

505

2355

N06AX26

ATC

vortioxetine; oral

1.7

57.1

1221

7581

F29

ICPC

Eye symptom/complaint other

1.6

57.0

1456

9446

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

57.0

3474

26792

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

57.0

891

5068

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

57.0

1333

8467

N89

ICPC

Migraine

1.9

56.8

707

3739

R29

ICPC

Respiratory symptom/complaint other

1.8

56.7

952

5529

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

56.7

2314

16606

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

56.7

3435

26465

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

56.6

1132

6904

U02

ICPC

Urinary frequency/urgency

1.5

56.5

1892

13044

A08

ICPC

Swelling

2.0

56.5

647

3326

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

56.4

651

3355

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

56.4

1025

6091

R07.0

ICD-10 Finland

Pain in throat

1.7

56.4

1188

7347

K08.3

ICD-10 Finland

Retained dental root

1.8

56.2

915

5267

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

56.2

308

1158

P18

ICPC

Medication abuse

4.2

56.1

151

365

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

55.6

877

5002

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

55.2

566

2795

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

55.2

3342

25726

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

55.1

562

2770

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

54.9

730

3945

SPAT1227

SPAT

Substance abuse rehabilitation

4.4

54.8

139

321

B02AA02

ATC

tranexamic acid; systemic

1.5

54.7

1909

13270

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.1

54.6

149

364

SPAT1265

SPAT

Breathalyser

3.7

54.5

173

471

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

54.3

718

3874

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.8

54.3

795

4431

K04.08

ICD-10 Finland

Other specified pulpit

1.6

54.2

1232

7765

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

54.2

786

4368

R4120

NOMESCO Finland

Occupational therapy

1.8

54.2

822

4632

N05BE01

ATC

buspirone; oral

2.3

54.1

410

1794

D02

ICPC

Abdominal pain epigastric

1.8

53.7

890

5149

K92.0

ICD-10 Finland

Haematemesis

2.7

53.7

295

1111

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

53.5

3477

27049

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

53.3

1561

10443

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

53.2

441

2004

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

53.2

1479

9781

UKC02

NOMESCO Finland

Cystoscopy

1.6

53.0

1495

9920

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

52.9

2474

18191

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

52.9

669

3557

T75.2

ICD-10 Finland

Effects of vibration

114.5

52.8

SFA10

NOMESCO Finland

One-surface restoration

1.3

52.6

7800

68266

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.1

52.5

110

217

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

52.4

1645

11174

N06AX03

ATC

mianserin; oral

2.1

52.2

544

2702

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.2

52.2

107

207

S01

ICPC

Pain/tenderness of skin

2.0

52.1

623

3249

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

52.1

773

4325

SPAT1272

SPAT

Drug screening

5.1

52.0

109

215

J01DA09

ATC

[U] cefadroxil

1.4

51.8

3309

25648

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

5.1

51.8

109

216

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

51.6

318

1267

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.2

51.6

435

1991

S20.2

ICD-10 Finland

Contusion of thorax

1.9

51.5

688

3725

R06AX26

ATC

fexofenadine; oral

1.7

51.3

955

5709

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

51.2

2946

22444

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

51.2

1006

6103

T70.3

ICD-10 Finland

Caisson disease [decompression sickness]

+∞

51.1

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

8.0

51.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

50.9

1000

6064

SPAT1312

SPAT

General health counselling

1.3

50.9

4256

34362

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

50.8

4934

40703

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

50.8

392

1730

Z01.2

ICD-10 Finland

Dental examination

1.3

50.7

6738

57997

W99

ICD-10 Finland

Exposure to other and unspecified man-made environmental factors

5.1

50.6

106

209

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.0

50.6

565

2877

N06AX05

ATC

trazodone; oral

2.4

50.4

359

1530

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

50.3

1243

7989

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.0

50.3

570

2918

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

50.2

824

4752

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

50.2

332

1368

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.2

50.1

411

1860

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

752

331

23.90

307.65

1.3

1.2

111.02

108.88

0.70

694

295

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

365

290

12.88

307.65

1.2

1.1

10.37

6.98

u/ml

0.39

263

190

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1407

4075

3.71

307.65

1.8

1.9

0.24

0.23

g/l

1.10

1300

3918

(3005322) IgE [Units/volume] in Serum or Plasma

2453

9541

2.89

307.65

1.5

1.3

391.14

221.14

u/ml

3.76

2354

8871

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5566

34442

2.00

307.65

2.7

2.2

234.51

203.25

u/l

1.07

5335

32715

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

773

364

22.37

307.65

1.3

1.2

0.31

0.29

g/l

2.17

603

298

(3019420) Tryptase [Mass/volume] in Serum or Plasma

963

625

16.42

307.65

1.5

1.6

8.39

7.39

ug/l

0.43

847

581

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1408

4205

3.60

307.65

1.8

1.20

1.18

g/l

1.80

1309

4053

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

378

117

33.14

307.65

1.1

1.0

0.38

0.22

u/ml

0.28

227

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8540

62470

1.89

289.81

6.9

6.3

10.46

11.20

umol/l

6.30

8147

59416

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

233

136

17.39

284.12

1.0

0.32

0.39

u/ml

0.09

141

(3022096) Basophils/Leukocytes in Blood

8279

60199

1.87

283.70

7.5

6.8

0.66

0.68

2.87

7842

56732

(3013115) Eosinophils [#/volume] in Blood

9077

67993

1.89

282.65

7.7

6.8

0.20

0.19

e9/l

8.95

8078

60040

(3019069) Monocytes/Leukocytes in Blood

8294

60409

1.86

281.97

7.5

6.8

8.41

8.62

10.29

7876

57064

(3013826) Glucose [Moles/volume] in Serum or Plasma

9333

70598

1.89

281.10

6.5

4.9

6.53

mmol/l

0.05

8946

65912

(3006504) Eosinophils/Leukocytes in Blood

8271

60263

1.86

280.05

7.5

6.7

2.90

2.82

2.48

7842

56881

(3006315) Basophils [#/volume] in Blood

8845

65826

1.87

279.79

7.4

6.6

0.04

e9/l

0.81

7728

57225

(3001604) Monocytes [#/volume] in Blood

8832

65713

1.87

279.43

7.4

6.6

0.57

0.56

e9/l

2.71

7722

57155

(3002030) Lymphocytes/Leukocytes in Blood

8459

62392

1.85

271.81

7.5

6.7

28.44

28.94

4.27

8110

59525

(3019198) Lymphocytes [#/volume] in Blood

8969

67484

1.85

268.89

7.5

6.6

1.98

1.95

e9/l

1.31

8045

60043

(3013650) Neutrophils [#/volume] in Blood by Automated count

9531

73174

1.87

266.87

10.6

9.7

4.23

4.03

e9/l

12.35

8358

63731

(3018010) Neutrophils/Leukocytes in Blood

8320

61330

1.83

264.86

7.3

6.6

56.87

56.54

1.90

8019

58912

(3032080) INR in Blood by Coagulation assay

7092

49949

1.82

261.13

12.7

12.0

1.16

1.20

inr

9.37

6051

41471

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

232

163

14.45

256.70

1.1

3.89

3.62

u/ml

0.05

181

130

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7848

57516

1.79

247.73

8.4

7.2

1.21

mmol/l

1.90

6934

50029

(3023368) Bacteria identified in Blood by Culture

4754

30127

1.86

242.55

5.0

4.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

221

159

14.10

241.25

1.1

1.0

4.97

0.48

u/ml

0.96

120

(3011841) English Walnut IgE Ab [Units/volume] in Serum

220

162

13.77

236.97

1.1

5.49

4.13

u/ml

0.25

172

128

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

215

153

14.25

236.15

1.1

1.0

0.70

0.14

u/ml

1.20

117

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

204

139

14.87

229.53

1.1

1.0

1.74

0.11

u/ml

1.09

111

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7092

51186

1.75

229.22

7.9

6.7

1.21

mmol/l

3.23

6662

47714

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11219

92682

1.91

227.00

9.5

7.9

77.28

77.26

u/l

0.02

10774

88318

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6044

41801

1.76

226.02

4.4

3.3

64.81

58.38

ng/l

0.07

3689

24865

(3012494) Peanut IgE Ab [Units/volume] in Serum

325

451

7.35

220.99

1.1

15.66

9.20

u/ml

0.31

239

266

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

198

138

14.53

220.00

1.1

1.0

1.16

1.59

u/ml

0.21

139

100

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4451

28342

1.82

218.91

2.1

1.9

1.00

1.13

mg/l

1.58

3347

21505

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

161

21.69

217.13

1.1

1.0

1.79

1.18

u/ml

0.18

152

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5638

38597

1.75

215.68

3.4

2.7

54.93

61.63

u/l

2.52

5257

35972

(3002582) Erythrocytes [#/volume] in Urine

5618

38742

1.73

207.08

4.0

3.3

65.57

67.26

e6/l

0.03

4440

29067

(3016031) Almond IgE Ab [Units/volume] in Serum

167

17.77

206.05

1.1

0.83

1.35

u/ml

0.45

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5996

42549

1.69

195.76

4.0

3.3

2.06

2.43

e6/l

—

(3021589) Normoblasts [#/volume] in Blood

7587

57310

1.67

194.88

13.0

10.8

0.00

e9/l

2.31

6247

46702

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

11028

92200

1.80

194.12

5.1

4.2

11.14

10.47

mm/h

6.06

10453

87106

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3121

18403

1.89

192.43

2.2

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

4936

33529

1.71

187.43

3.9

3.2

0.32

0.37

e6/l

0.92

3746

24054

(36304419) Bacteria [Presence] in Urine

4785

32289

1.72

185.78

3.8

3.1

172.51

125.21

estimate

0.09

114

(3018095) Leukocytes [#/volume] in Urine

6335

46050

1.66

185.53

4.8

3.8

81.34

81.79

e6/l

0.01

4663

31290

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

155

16.48

184.32

1.0

2.78

2.06

u/ml

0.17

125

(3037467) Urinalysis macro (dipstick) panel - Urine

10399

86165

1.72

180.75

5.5

4.3

2.14

6.80

0.54

116

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3432

21212

1.81

180.19

4.4

3.6

370.39

453.71

ng/l

0.19

2232

14709

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6049

43731

1.65

178.95

3.7

3.3

32.86

33.00

u/l

0.04

5710

41488

(3028707) Methadone [Presence] in Urine by Screen method

972

3689

2.75

175.71

4.2

2.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

9979

82049

1.68

175.46

5.9

4.3

1005.25

1777.98

e6/l

1.06

159

1041

(3027231) Wheat IgE Ab [Units/volume] in Serum

247

332

7.55

172.69

1.2

1.1

9.57

1.98

u/ml

1.02

205

297

(3024561) Albumin [Mass/volume] in Serum or Plasma

6928

52192

1.62

171.15

5.6

5.1

36.25

36.42

g/l

1.75

6544

49160

(3026782) Osmolality of Urine

3541

22386

1.77

170.77

3.2

2.8

523.10

535.36

mosm/kgh2o

2.34

3182

19631

(3000850) Epithelial cells [#/volume] in Urine

4021

26353

1.73

170.65

3.1

2.7

7.03

6.23

e6/l

2.41

3705

23935

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

155

112

13.98

168.69

1.1

0.33

0.30

u/ml

0.05

155

112

(3033658) Prothrombin time (PT) actual/Normal

4533

31092

1.66

160.15

4.8

4.2

92.71

92.15

0.83

4422

30369

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

423

1030

4.20

155.40

1.3

3.65

2.49

u/ml

1.08

327

571

(3019550) Sodium [Moles/volume] in Serum or Plasma

13511

123259

2.31

152.36

22.8

15.4

139.51

139.64

mmol/l

9.30

13362

120809

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2056

11351

1.94

151.16

4.7

4.5

5.84

5.82

kpa

0.34

2001

11069

(3023103) Potassium [Moles/volume] in Serum or Plasma

13515

123531

2.28

147.91

23.0

15.5

3.93

3.94

mmol/l

9.74

13346

120808

(3012544) pH of Venous blood

2062

11491

1.93

147.12

4.7

4.5

7.38

0.21

1159

6620

(3018418) pH of Serum or Plasma

4834

34255

1.61

147.01

4.6

4.2

7.40

0.43

3456

24152

(3014111) Lactate [Moles/volume] in Serum or Plasma

1867

10081

1.98

146.13

8.3

8.4

1.42

1.32

mmol/l

2.84

1841

9890

(3002032) Base excess in Venous blood by calculation

1998

11045

1.94

145.95

4.7

4.6

1.57

1.70

mmol/l

0.80

1756

9621

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2306

13402

1.86

144.22

2.0

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13662

125651

2.38

143.63

21.6

13.9

20.61

22.43

mg/l

10.42

12015

101701

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2963

18579

1.75

143.49

2.4

1.8

1.55

1.41

19.46

2597

16648

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

125

15.18

142.51

1.1

1.0

16.34

20.72

u/ml

0.26

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6606

50675

1.55

140.85

2.3

2.0

95.82

97.15

pmol/l

1.57

3756

27475

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

130

13.65

139.69

1.5

1.4

12.20

2.18

u/ml

1.26

116

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

24.66

139.01

1.1

1.37

1.19

u/ml

0.06

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2184

12712

1.84

135.17

2.1

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

3043

19521

1.71

134.56

1.5

1.4

521.82

520.05

titre

0.02

593

4006

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2078

11975

1.86

132.57

2.8

2.6

67.61

42.58

u/l

0.33

1760

10173

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3010

19369

1.70

131.13

3.9

3.8

0.81

0.82

mmol/l

2.02

2863

18339

(3024354) Oxygen [Partial pressure] in Venous blood

1737

9515

1.94

129.31

4.2

4.0

4.70

4.66

kpa

0.31

1682

9262

(40758558) Short blood count panel - Blood

5096

37432

1.56

128.43

6.9

6.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2754

17408

1.72

127.73

2.3

2.4

29.64

29.50

0.58

2681

16918

(3003888) Timothy IgE Ab [Units/volume] in Serum

846

3507

2.50

126.95

1.2

1.1

4.76

5.90

u/ml

1.43

577

1936

(3020191) Ethanol [Moles/volume] in Serum or Plasma

413

1148

3.67

125.91

2.0

1.4

1.58

1.23

promille

3.98

307

890

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

918

4015

2.37

122.33

1.2

1.1

2.32

2.31

u/ml

0.01

629

2155

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

12891

117295

1.85

120.52

18.8

13.0

89.31

87.84

ml/min/173m2

11.97

11997

106856

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1254

6295

2.09

118.94

2.1

1.7

0.33

0.30

mg/l

1.50

648

2906

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2941

19234

1.66

118.94

3.5

3.0

4.15

3.04

e6/l

3.71

1453

9033

(3007853) Bacteria identified in Skin by Aerobe culture

2399

14887

1.73

117.93

1.9

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

4422

31935

1.55

117.83

1.8

1.6

19.30

19.99

nmol/l

2.59

3853

27726

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

876

3828

2.37

116.85

2.3

600.87

523.80

ug/l

0.29

821

3581

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10542

91366

1.55

116.59

4.4

3.2

47.22

41.63

u/l

8.56

10072

87092

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

318

777

4.16

116.21

1.9

1.8

3.88

2.41

u/ml

0.40

242

(3021601) Nitrite [Presence] in Urine by Test strip

8233

67874

1.49

114.69

4.5

3.6

0.00

estimate

0.69

1943

14146

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11430

101076

1.60

114.18

5.2

4.4

14.52

14.57

pmol/l

1.20

10754

94167

(3007164) IgA [Mass/volume] in Serum or Plasma

4173

29932

1.55

113.82

1.6

1.5

2.27

2.25

g/l

0.44

2593

19365

(3010726) Horse dander IgE Ab [Units/volume] in Serum

795

3366

2.44

113.73

1.2

1.1

2.81

1.97

u/ml

1.36

533

1759

(3009261) Glucose [Presence] in Urine by Test strip

8333

68968

1.49

113.07

4.5

3.7

0.54

0.26

estimate

0.22

1889

13690

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

123

118

10.50

111.92

1.1

1.0

7.25

8.51

u/ml

0.22

(3008401) Mugwort IgE Ab [Units/volume] in Serum

791

3370

2.42

111.58

1.2

1.1

1.30

1.12

u/ml

0.30

509

1528

(3013512) EKG study

4880

36330

1.52

111.53

3.8

3.3

0.80

0.75

—

(3035350) Ketones [Presence] in Urine by Test strip

8285

68600

1.48

111.37

4.5

3.7

8.13

3.76

estimate

1.14

1970

14300

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2318

14455

1.72

111.32

2.8

2.9

6.87

7.66

umol/l

1.00

1953

12557

(3011288) Drugs identified in Urine by Screen method Nominal

1250

6418

2.04

111.22

5.0

2.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3994

28571

1.55

109.41

3.2

3.1

1201.85

1157.43

ng/l

0.23

3333

24107

(3036312) Salmon IgE Ab [Units/volume] in Serum

104

13.08

109.07

1.1

2.66

0.89

u/ml

0.72

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

114

102

11.26

108.75

1.1

1.0

0.06

0.03

u/ml

2.28

114

102

(3015377) Calcium [Moles/volume] in Serum or Plasma

5309

40461

1.49

107.14

3.4

2.35

mmol/l

1.26

4884

37186

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3084

20897

1.60

106.52

3.4

2.9

1.25

1.23

e6/l

0.03

1611

10757

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4396

32347

1.51

104.64

2.6

2.3

2.62

2.69

mg/l

1.37

3850

28193

(3015736) pH of Urine

6840

54966

1.46

104.39

3.9

3.3

6.20

6.22

0.99

3973

31031

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2088

12863

1.73

104.19

2.5

2.2

366.42

378.31

nmol/l

1.35

1954

11983

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4634

34621

1.50

101.84

1.4

1.67

1.70

u/ml

0.05

1264

9853

(3022948) Iron [Moles/volume] in Serum or Plasma

3019

20542

1.59

101.81

2.8

2.6

13.12

13.76

umol/l

4.88

2801

19302

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1452

8102

1.88

100.77

9.6

9.3

24.73

24.72

mmol/l

0.01

1441

8058

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1316

7124

1.93

100.15

4.7

4.9

24.15

24.14

mmol/l

0.03

1298

7052

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12761

117050

1.72

98.87

6.5

5.3

1.80

1.83

mu/l

0.84

12151

110436

(4198724) Urine methamphetamine measurement

314

856

3.73

98.46

2.7

2.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2582

17118

1.62

96.40

1.8

1.7

1122.96

1168.97

nmol/l

1.78

1990

13248

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2807

18995

1.59

96.17

2.8

2.6

2.39

g/l

0.31

2557

17676

(3016502) Oxygen saturation in Arterial blood

1792

10814

1.75

95.63

9.3

8.6

95.40

95.84

1.82

1744

10424

(3042936) Bacteria identified in Isolate by Culture

2548

16894

1.62

94.93

2.2

2.0

—

(40768797) Stomach Pathology biopsy report

2486

16392

1.62

94.72

1.3

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1457

8293

1.84

94.64

1.7

—

(3003396) Base excess in Arterial blood by calculation

1957

12164

1.70

93.71

9.0

8.2

0.77

0.80

mmol/l

0.11

1626

9927

(3044640) Blood type and Crossmatch panel - Blood

5226

40476

1.45

93.51

2.7

2.3

—

(3016879) Cocaine [Presence] in Urine

1486

8556

1.82

92.88

3.6

2.0

—

(3019977) pH of Arterial blood

1963

12271

1.69

91.89

9.2

8.3

7.41

7.42

2.73

1043

6561

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3518

25264

1.52

91.65

1.4

1.3

25.92

29.05

iu/ml

0.71

950

7412

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2586

17350

1.60

91.31

2.8

2.6

22.08

23.24

4.16

2372

16232

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1691

10191

1.75

90.32

9.7

9.1

123.55

121.82

g/l

2.77

1666

9945

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1951

12257

1.68

89.44

9.1

8.2

5.11

5.08

kpa

0.64

1895

11798

(3027801) Oxygen [Partial pressure] in Arterial blood

1950

12252

1.68

89.35

9.1

8.2

12.30

12.96

kpa

6.32

1894

11792

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3273

23283

1.52

88.69

1.4

1.3

8.66

9.80

u/ml

0.49

1199

9619

(3000764) Benzodiazepines [Presence] in Urine

1552

9191

1.77

87.98

3.6

2.0

—

(3028300) Cannabinoids [Presence] in Urine

1560

9261

1.77

87.68

3.6

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1173

6407

1.90

86.38

1.9

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7009

57789

1.41

86.29

2.9

2.5

72.99

1604.01

nmol/l

0.50

6484

53634

(3027008) Opiates [Presence] in Urine

1552

9240

1.76

86.28

3.6

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

329

1038

3.22

82.22

1.2

1.1

1.78

0.89

u/ml

0.51

185

261

(3048689) Calprotectin [Mass/mass] in Stool

2837

19855

1.53

82.04

2.6

114.65

122.38

ug/g

0.62

2244

15854

(3027944) Amphetamines [Presence] in Urine

1523

9144

1.74

81.97

3.4

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1330

7679

1.81

81.88

4.7

4.2

5.15

5.12

kpa

0.60

1286

7363

(3009343) pH of Capillary blood

1299

7471

1.81

80.97

4.7

4.2

7.41

0.11

1113

6180

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3241

23396

1.50

80.65

2.6

2.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3463

25451

1.47

78.41

2.7

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2273

15278

1.58

78.36

6.9

6.5

1.06

mmol/l

0.01

2167

14301

(3020874) Milk IgE Ab [Units/volume] in Serum

351

1187

3.00

77.92

1.3

1.1

8.31

1.77

u/ml

1.74

226

405

(3004119) Hemoglobin [Mass/volume] in Venous blood

1182

6684

1.84

77.75

3.7

3.8

131.42

130.72

g/l

0.50

1150

6512

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7117

59510

1.38

76.99

3.1

2.8

—

estimate

—

(3023511) Choriogonadotropin [Units/volume] in Urine

864

4449

2.00

75.39

1.6

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13871

131976

2.04

75.31

24.7

16.9

74.18

73.73

umol/l

0.89

13790

130562

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7945

67804

1.38

74.85

3.7

3.2

104.84

100.95

ug/l

0.77

7463

64298

(3014599) Egg white IgE Ab [Units/volume] in Serum

338

1148

2.99

74.46

1.3

1.1

14.99

1.54

u/ml

1.49

197

298

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1159

6601

1.82

74.36

4.5

4.2

1.78

1.51

mmol/l

1.67

843

4793

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1467

8992

1.70

72.79

1.6

1.5

—

(3044889) 12 lead EKG panel

9349

82144

1.38

72.27

4.1

3.6

0.33

2986.15

0.68

138

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

40.11

72.18

1.0

1.1

0.66

0.45

u/ml

0.15

(3009508) Creatinine [Moles/volume] in Urine

5008

39874

1.39

71.18

4.0

3.5

7.71

7.91

mmol/l

1.94

4286

34588

(3020779) Urea [Moles/volume] in Serum or Plasma

1586

9984

1.66

71.02

8.1

8.3

8.64

8.87

mmol/l

0.67

1534

9596

(3005719) IgG [Mass/volume] in Serum or Plasma

1631

10356

1.65

70.59

2.7

2.8

10.35

10.49

g/l

0.73

1505

9602

(3014051) Protein [Presence] in Urine by Test strip

4838

38354

1.39

70.36

3.3

2.8

0.13

0.05

0.73

657

(3014133) Dog dander IgE Ab [Units/volume] in Serum

626

2948

2.17

69.26

1.1

5.78

4.45

u/ml

0.98

401

1528

(3017143) Hepatitis C virus Ab [Presence] in Serum

2751

19735

1.49

69.10

1.8

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

747

3777

2.03

68.48

3.5

3.2

24.64

24.57

mmol/l

0.20

735

3718

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3984

30721

1.41

67.60

2.7

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

594

2769

2.19

67.41

1.1

6.15

5.81

u/ml

0.16

360

1290

(3027945) Reticulocytes/Erythrocytes in Blood

1843

12303

1.57

64.38

2.6

2.9

1.78

1.75

0.65

1649

11073

(3026493) Urate [Moles/volume] in Serum or Plasma

3975

30863

1.40

64.08

2.7

2.6

334.97

331.00

umol/l

1.67

3508

27824

(3042517) Benzodiazepines panel - Urine

122

221

5.56

63.94

3.7

2.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1146

6790

1.75

63.93

11.5

10.7

0.61

0.64

2.56

1140

6750

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

540

2483

2.22

63.37

1.1

0.61

0.43

u/ml

0.38

263

775

(3021901) Oxygen saturation in Capillary blood

502

2249

2.28

62.73

3.4

3.2

91.11

90.81

0.48

494

2191

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

223

658

3.43

62.13

3.3

2.2

210.88

145.97

umol/l

1.41

108

327

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

22.56

61.54

1.0

0.14

0.02

u/ml

0.61

(40767503) Oxygen content in Capillary blood by calculation

504

2284

2.25

61.27

3.1

2.5

16.73

16.76

0.09

493

2238

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1085

6405

1.75

61.23

11.4

10.5

24.14

24.19

mmol/l

0.20

1070

6282

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1162

6996

1.72

61.11

11.3

10.4

1.36

1.33

0.54

1156

6953

(40760892) CBC W Ordered Manual Differential panel - Blood

3985

31246

1.38

59.65

5.0

4.5

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

15.34

59.63

1.0

0.75

0.33

u/ml

0.41

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

905

5114

1.82

59.19

5.2

4.0

51.24

48.39

2.86

886

5035

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2937

21909

1.43

58.75

2.8

2.44

mmol/l

0.01

2615

19608

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1056

6257

1.74

58.74

10.6

10.5

16.22

16.11

0.63

1035

6025

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1871

12771

1.53

58.73

3.9

4.6

228.66

239.00

u/l

2.98

1775

12165

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12416

115907

1.48

58.67

5.2

4.5

5.88

5.78

mmol/l

11.07

11619

108518

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6180

51943

1.33

58.09

4.3

3.5

0.40

0.24

estimate

0.21

1643

11763

(3017181) Myelocytes/Leukocytes in Blood

1646

10947

1.57

58.03

4.7

0.81

0.91

0.64

493

3108

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1650

10988

1.57

57.83

4.0

3.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

989

5778

1.76

57.78

2.0

1.9

6.21

7.08

iu/ml

0.42

226

1395

(3021440) Promyelocytes/Leukocytes in Blood

1589

10503

1.58

57.52

4.8

0.12

0.01

433

2676

(3002179) Metamyelocytes/Leukocytes in Blood

1581

10462

1.57

56.91

4.5

0.55

0.68

1.81

482

2965

(3028026) IgM [Mass/volume] in Serum or Plasma

1279

8043

1.65

56.87

1.9

1.40

1.28

g/l

1.17

1187

7485

(3025159) Blasts/Leukocytes in Blood

1610

10706

1.57

56.72

4.9

0.10

0.30

1.29

413

2578

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13756

131677

1.79

56.28

14.5

11.0

27.56

26.65

u/l

4.80

13530

128570

(3023183) Ammonium ion [Moles/volume] in Plasma

521

2476

2.14

56.25

2.5

2.9

32.66

34.34

umol/l

0.98

480

2268

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1267

7983

1.64

55.87

2.6

2.3

5.35

7.35

ug/l

4.38

1105

7025

(3028626) Oxygen [Partial pressure] in Capillary blood

649

3368

1.97

55.13

5.5

4.8

8.55

8.72

kpa

1.75

632

3285

(1616796) Gas panel - Central venous blood

521

2497

2.13

55.03

4.2

3.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

398

1712

2.36

54.66

2.2

1.8

1.74

1.69

mmol/l

0.34

389

1671

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1405

9127

1.60

54.63

2.9

2.4

8643.07

6144.26

u/l

1.41

528

3631

(46235355) HIV 1 and 2 tests - Meaningful Use set

4452

35900

1.35

54.59

2.4

2.1

—

(3024928) Oxygen saturation in Venous blood

581

2921

2.03

53.98

2.9

4.2

62.32

62.88

0.24

556

2836

(3011397) Hemoglobin [Presence] in Urine by Test strip

3881

30692

1.36

53.93

4.1

3.6

0.77

0.41

0.47

252

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1661

11258

1.54

53.51

2.4

2.5

0.22

g/l

0.07

1534

10561

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12104

112949

1.42

52.62

6.4

5.5

38.60

38.18

mmol/mol

5.47

11501

107309

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1446

9541

1.57

52.48

2.5

2.4

17.91

20.30

au/ml

0.70

159

1167

(3041096) Erythrocytes [Presence] in Urine by Automated

4710

38507

1.33

51.94

3.8

3.0

0.17

0.11

estimate

0.13

1653

11486

(3009466) Valproate [Moles/volume] in Serum or Plasma

411

1837

2.27

51.64

6.1

5.8

361.50

370.59

umol/l

0.57

358

1617

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

310

1221

2.57

51.53

2.4

2.3

—

(3027315) Oxygen [Partial pressure] in Blood

482

2321

2.11

50.28

4.2

3.9

8.88

8.82

kpa

0.34

471

2274

(3022145) Colonoscopy Study observation

1972

14015

1.47

50.25

1.4

—

(3012501) Base excess in Blood by calculation

479

2303

2.12

50.17

4.2

3.9

2.16

2.34

mmol/l

0.81

308

1520

(3013290) Carbon dioxide [Partial pressure] in Blood

479

2304

2.12

50.12

4.2

3.9

5.01

kpa

0.04

468

2258

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

11700

108785

1.38

49.93

24.7

16.9

13.55

13.44

20.04

11632

107397

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1351

8875

1.58

49.86

1.4

1.3

38.45

49.27

au/ml

1.16

549

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1004

6129

1.69

49.84

2.3

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3066

23600

1.38

49.84

1.8

1.7

18329273.90

30552419.72

pmol/l

0.86

2597

20254

(3029937) Albumin [Presence] in Urine by Test strip

4491

36634

1.33

49.79

4.6

3.8

0.00

estimate

0.09

1854

13273

(3000494) Fungus identified in Specimen by Culture

2123

15330

1.45

49.74

1.5

—

(3010421) pH of Blood

650

3520

1.89

48.55

4.1

3.7

7.41

0.02

639

3478

(3017732) Neutrophils [#/volume] in Blood

2226

16283

1.43

48.52

3.2

3.1

4.32

4.38

e9/l

0.32

1943

14402

(3000570) Elastase.pancreatic [Mass/mass] in Stool

655

3565

1.88

48.16

1.5

1.4

287.37

279.67

ug/g

0.38

357

1994

(3023520) Reticulocytes [#/volume] in Blood

1384

9215

1.55

48.05

2.7

70.80

70.02

e9/l

0.31

972

6605

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

606

3232

1.91

47.42

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1612

11170

1.50

46.36

1.3

1.2

130.44

142.23

u/ml

0.43

560

4337

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

11.78

46.25

1.1

1.0

0.06

0.04

u/ml

0.58

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

657

3637

1.84

45.77

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

785

4588

1.75

45.58

4.3

3.5

25.08

25.18

mmol/l

0.34

758

4425

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1316

8769

1.55

45.42

4.2

3.8

1.22

1.23

mmol/l

1.75

1141

7639

(3015171) Extractable nuclear Ab [Units/volume] in Serum

897

5455

1.69

45.07

1.3

2.11

1.01

u/ml

0.82

418

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

757

4397

1.76

44.91

1.2

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

685

3904

1.79

43.34

1.4

1.3

10.46

8.42

u/ml

0.26

572

(3052851) Hemolysis interference index of Serum or Plasma

598

3275

1.86

43.09

2.9

3.0

1.61

2.22

index

1.38

337

1714

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1375

9353

1.52

43.05

2.7

2.4

0.41

0.39

e6/l

0.09

1312

8896

(3025941) Bacteria identified in Stool by Culture

1162

7617

1.57

43.03

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

683

3908

1.78

42.64

1.4

1.3

4.44

6.42

u/ml

0.47

371

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

719

4195

1.75

41.96

1.4

1.3

37.87

37.00

u/ml

0.03

245

(3017958) Strawberry IgE Ab [Units/volume] in Serum

10.48

41.91

1.0

0.21

0.05

u/ml

0.52

(3013139) Helicobacter pylori Ag [Presence] in Stool

1328

9033

1.52

41.52

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

305

1329

2.32

40.73

2.0

1.8

90.46

90.32

0.16

300

1311

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

447

2276

1.99

40.07

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

447

2276

1.99

40.07

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

1687

12115

1.44

40.03

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

170

5.02

40.02

1.1

17.84

0.52

u/ml

0.51

(3008152) Bicarbonate [Moles/volume] in Arterial blood

985

6322

1.60

39.84

7.4

6.8

24.30

24.41

mmol/l

0.37

952

6030

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3653

29675

1.31

39.76

1.9

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1272

8649

1.52

39.76

2.6

2.5

66.61

66.64

g/l

0.05

1189

8016

(3009445) Proteinase 3 Ab [Units/volume] in Serum

826

5110

1.65

38.76

1.4

1.6

6.88

12.76

iu/ml

1.71

162

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

768

4684

1.67

38.07

5.3

5.0

1.82

1.66

2.79

735

4421

(3045414) Leukocytes [Presence] in Urine

1624

11687

1.44

37.98

2.2

2.0

0.03

estimate

0.09

348

2634

(3048929) Epstein Barr virus Ab [Presence] in Serum

931

6015

1.58

36.55

1.4

1.3

—

(3007463) Buprenorphine [Presence] in Urine

6.98

36.34

9.9

5.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

322

1505

2.16

36.33

1.2

1.3

0.18

0.19

nmol/l

0.62

222

1161

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

207

797

2.62

36.16

2.2

1.6

1652446.92

1859451.40

iu/ml

0.09

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

358

1748

2.07

36.05

1.2

1.3

0.52

2.47

nmol/l

0.96

344

1695

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

173

611

2.85

35.70

1.0

12.70

10.69

u/ml

0.42

413

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

835

5297

1.61

35.38

1.6

1.7

14.76

12.37

u/ml

0.44

166

1442

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

605

3535

1.74

35.09

1.3

1.5

477.88

497.38

mg/l

0.22

585

3390

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

494

2721

1.84

34.95

2.2

0.00

g/l

-0.00

472

2558

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

362

1796

2.04

34.91

1.2

1.3

0.26

0.22

nmol/l

0.20

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

540

3059

1.79

34.85

2.1

0.02

0.03

g/l

0.33

501

2765

(40761536) Microorganisms panel - Urine sediment

1462

10477

1.44

34.81

4.7

3.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

561

3216

1.77

34.77

1.3

5.21

3.83

u/ml

0.21

215

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

581

3371

1.75

34.54

1.4

1.5

17.95

10.83

iu/ml

0.46

(3007456) Orange IgE Ab [Units/volume] in Serum

10.02

34.44

1.1

1.0

0.05

0.08

u/ml

0.40

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

518

2912

1.81

34.29

2.1

2.2

0.00

g/l

0.28

471

2562

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

524

2957

1.80

34.25

1.7

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

656

3948

1.69

34.17

2.1

1.9

1.66

2.24

ug/l

0.97

585

3510

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

555

3199

1.76

33.76

1.8

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

4119

34552

1.27

33.69

4.5

4.3

14.58

9.20

mg/mmol

0.67

2613

21912

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

671

4090

1.67

33.30

2.2

7.23

7.33

g/l

0.91

632

3777

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2084

15973

1.36

33.18

2.4

2.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

643

3882

1.69

33.09

2.1

2.2

2.88

g/l

0.02

604

3571

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

669

4086

1.67

32.94

2.2

4.23

g/l

0.09

630

3775

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

596

3534

1.72

32.79

2.2

2.3

0.68

0.75

g/l

0.21

541

3073

(3019150) Specific gravity of Urine by Refractometry

3681

30541

1.27

32.79

4.3

3.7

1.02

1.17

kg/l

1.08

2529

19758

(3020891) Body temperature

765

4846

1.61

32.57

5.7

4.5

36.93

36.92

°c

0.22

754

4802

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

667

4083

1.66

32.56

2.2

3.73

3.68

g/l

0.30

626

3773

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1290

9141

1.45

32.53

3.2

3.5

4.54

4.56

pmol/l

0.34

1172

8298

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

544

3153

1.75

32.46

1.2

1.4

3.67

mmol/l

0.05

516

2993

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

593

3522

1.71

32.43

2.2

10.14

10.18

g/l

0.08

549

3182

(3000330) Specific gravity of Urine by Test strip

846

5496

1.57

32.36

3.4

3.1

1.02

ratio

0.86

746

4870

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

554

3233

1.74

32.27

1.3

48.85

44.74

u/ml

0.21

293

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

9.09

32.07

1.1

1.0

0.15

0.08

u/ml

0.28

(3019225) pH of Specimen

1401

10122

1.42

31.76

4.2

4.0

7.37

7.36

1.88

1062

7272

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

837

5448

1.57

31.74

2.0

39.55

39.98

u/l

0.26

775

4960

(3022313) Gas panel - Capillary blood

822

5333

1.57

31.62

5.1

4.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

688

4277

1.64

31.61

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1062

7291

1.49

31.45

1.2

1.1

30.81

2.41

u/ml

0.44

(3024980) IgG subclass 4 [Mass/volume] in Serum

430

2345

1.86

31.42

1.6

0.71

0.72

g/l

0.06

347

1834

(3007930) Methemoglobin/Hemoglobin.total in Blood

685

4277

1.63

30.92

5.5

5.3

0.86

0.89

1.10

655

4035

(3022621) pH of Urine by Test strip

1386

10072

1.42

30.34

2.7

2.4

6.07

6.13

1.49

884

6454

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1759

13321

1.36

30.03

2.2

2.1

—

(3012516) Albumin [Mass/volume] in Urine

4026

34041

1.25

30.00

3.8

3.6

55.69

53.12

mg/l

0.24

2660

21929

(3018001) Oat IgE Ab [Units/volume] in Serum

126

5.02

29.74

1.0

1.71

0.15

u/ml

0.55

(3036489) Thrombin time

794

5182

1.56

29.74

2.3

2.5

20.25

20.81

2.78

713

4537

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

8.14

29.43

1.1

1.0

0.16

0.09

u/ml

0.30

(40768443) Skin Pathology biopsy report

825

5451

1.54

29.24

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1088

7628

1.46

28.90

3.1

3.0

150.93

166.47

ng/l

0.74

973

6886

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

843

5611

1.53

28.89

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1196

8538

1.44

28.86

4.7

4.1

89.75

86.08

ng/l

0.63

1043

7539

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

521

3088

1.71

28.71

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

300

1498

2.02

28.49

1.6

—

(3007461) Platelets [#/volume] in Blood

14133

138204

1.73

28.48

31.2

21.2

260.54

257.37

e9/l

7.44

13981

135797

(3024731) MCV [Entitic mean volume] in Red Blood Cells

14135

138249

1.73

28.18

31.0

21.0

90.57

90.39

5.03

14080

137118

(3021387) Prolactin [Units/volume] in Serum or Plasma

1035

7223

1.47

28.14

1.8

1.6

340.09

306.95

mu/l

1.74

932

6533

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

364

1954

1.88

27.98

1.7

—

(3035941) MCH [Entitic mass]

14134

138253

1.72

27.95

31.0

21.0

30.19

30.16

1.12

14078

137127

(3008037) Lactate [Moles/volume] in Venous blood

422

2374

1.80

27.91

3.9

2.9

1.49

1.53

mmol/l

0.58

405

2310

(3026361) Erythrocytes [#/volume] in Blood

14135

138273

1.72

27.84

31.1

21.1

4.51

4.54

e12/l

8.88

13952

135538

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

14133

138267

1.71

27.57

31.8

21.5

40.42

41.16

6.61

14078

137074

(3000963) Hemoglobin [Mass/volume] in Blood

14136

138308

1.72

27.51

31.4

21.3

135.12

136.00

g/l

11.69

14083

137203

(3018405) Lactate [Moles/volume] in Arterial blood

538

3255

1.68

27.47

4.6

3.9

1.50

1.40

mmol/l

0.97

529

3192

(3010813) Leukocytes [#/volume] in Blood

14134

138301

1.71

27.26

31.2

21.2

7.02

6.70

e9/l

47.94

13953

135534

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

518

3112

1.69

27.16

1.3

1.6

15.60

23.42

e6/l

0.89

373

2284

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

524

3162

1.68

27.03

1.4

1.6

2013.49

2124.57

e6/l

0.02

404

2476

(3047181) Lactate [Moles/volume] in Blood

540

3297

1.66

26.63

5.4

5.7

1.41

1.27

mmol/l

2.53

494

2903

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

743

4898

1.54

26.59

1.9

1.8

1.57

1.47

g/l

1.95

643

4239

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

679

4387

1.57

26.56

2.3

2.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

347

1868

1.88

26.46

1.2

35.63

16.58

u/ml

0.59

(3006184) Hemoglobin [Mass/volume] in Capillary blood

460

2709

1.72

25.97

2.8

2.2

131.08

131.02

g/l

0.02

377

2127

(3007542) Rye IgE Ab [Units/volume] in Serum

5.33

25.80

1.1

32.56

0.24

u/ml

0.51

(3014765) Yersinia sp identified in Stool by Organism specific culture

561

3510

1.62

25.12

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

294

1525

1.95

25.10

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

111

376

2.97

24.85

1.3

1.2

95.92

93.19

0.44

111

371

(3024891) Influenza virus A+B Ag [Presence] in Specimen

631

4082

1.57

24.55

1.2

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

213

990

2.17

24.52

12.9

13.3

0.57

0.60

mmol/l

1.27

196

914

(42529406) Shigella sp [Presence] in Stool by Culture

560

3526

1.61

24.44

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12015

114797

1.26

24.38

4.2

3.9

1.35

1.26

mmol/l

30.16

11259

108077

(3027135) IgG subclass 1 [Mass/volume] in Serum

282

1457

1.95

24.37

1.5

1.3

6.39

6.64

g/l

0.65

215

1045

(3011985) Renin [Units/volume] in Plasma

338

1857

1.84

24.20

1.6

98.15

65.50

mu/l

0.66

308

1686

(3024139) IgG subclass 3 [Mass/volume] in Serum

281

1457

1.95

24.04

1.5

1.3

0.33

0.39

g/l

2.97

212

1041

(3028192) IgG subclass 2 [Mass/volume] in Serum

281

1457

1.95

24.04

1.5

1.3

2.75

2.94

g/l

1.15

214

1048

(3011648) Oxygen content in Venous blood

260

1316

1.99

23.85

2.0

4.1

11.05

11.04

0.01

260

1311

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

613

3967

1.57

23.82

1.2

4.22

4.29

0.06

624

(3003181) Sodium [Moles/volume] in Urine

342

1900

1.82

23.63

1.8

1.5

58.65

63.06

mmol/l

1.11

267

1521

(4062490) Immunoglobulin typing, IgG

276

1434

1.94

23.48

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

618

4025

1.56

23.35

2.1

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

284

1496

1.92

23.20

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

284

1496

1.92

23.20

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

217

1039

2.10

23.17

2.0

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

5.37

22.99

1.0

29.44

0.58

u/ml

0.49

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12744

122834

1.30

22.86

5.5

5.1

2.74

2.78

mmol/l

4.93

12041

116448

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

314

1717

1.85

22.85

1.4

673.77

389.89

pmol/l

0.40

267

1479

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

537

3415

1.59

22.50

1.9

2.1

11.19

11.15

mg/l

0.04

516

3215

(44813793) Dust mix specific IgE antibody measurement

218

1059

2.07

22.42

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

478

2959

1.64

22.37

3.3

57.97

57.50

0.36

478

2959

(3016650) Hepatitis A virus Ab [Presence] in Serum

418

2501

1.69

22.31

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

546

3499

1.58

22.14

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

272

1436

1.91

22.09

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

271

1430

1.91

22.04

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

272

1438

1.91

22.00

1.5

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

202

3.58

21.94

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

232

1165

2.01

21.80

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

230

1154

2.01

21.67

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

254

1322

1.94

21.54

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

230

1157

2.00

21.52

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

412

2480

1.68

21.51

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1126

8358

1.38

21.49

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1195

1.98

21.32

1.2

—

(3002256) Pathology report gross observation

1999

16120

1.28

21.24

1.3

—

(3008898) HLA-B27 [Presence]

828

5839

1.44

21.23

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

631

4218

1.52

21.18

2.9

179.17

181.98

0.34

598

4022

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

641

4301

1.51

21.13

2.8

3.2

3.59

3.54

g/l

0.38

604

4107

(4024509) Urine culture

773

5386

1.46

21.12

2.1

1.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

651

4384

1.51

21.09

5.4

4.6

24.79

24.59

mmol/l

1.07

616

4093

(3021788) Differential panel - Synovial fluid

357

2081

1.73

20.98

1.7

1.5

—

1.00

—

(3045716) Anion gap in Serum or Plasma by calculation

227

1150

1.99

20.83

3.7

3.2

10.45

10.75

mmol/l

0.54

221

1133

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

443

2746

1.63

20.64

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

596

3965

1.52

20.46

1.3

105.00

117.10

titre

0.22

403

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

542

3532

1.55

20.45

1.4

1.3

40.78

49.92

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

135

560

2.42

20.38

1.2

1.1

3.50

4.08

iu/ml

0.35

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

375

2236

1.69

20.31

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

513

3315

1.57

20.09

1.4

1.3

276.65

250.45

u/ml

0.98

319

2081

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

175

818

2.15

19.95

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12610

121731

1.26

19.89

5.0

4.6

4.62

4.68

mmol/l

10.30

11968

115875

(3042951) Complement C1q Ab [Units/volume] in Serum

5.73

19.72

1.1

9.47

27.61

u/ml

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

219

1118

1.97

19.69

1.3

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

266

1449

1.85

19.66

1.6

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

218

1120

1.96

19.26

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

497

3222

1.56

19.20

3.4

4.1

0.34

iu/ml

0.13

256

1736

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12543

121127

1.25

18.94

4.9

4.5

1.41

1.46

mmol/l

34.37

11851

114784

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

305

1757

1.75

18.73

1.1

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

513

3389

1.53

18.22

2.4

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

346

2.73

18.19

3.7

4.0

5.11

4.86

kpa

1.54

346

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

266

1487

1.80

18.11

6.3

6.9

11.19

11.28

mg/l

0.11

251

1389

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

347

2.72

18.09

3.7

4.0

10.41

10.64

kpa

0.24

347

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

450

2895

1.57

18.00

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

325

1933

1.70

17.82

4.1

3.0

7.10

7.47

mmol/l

1.40

314

1883

(3018333) Ribosomal P Ab [Presence] in Serum

209

1088

1.93

17.80

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

366

2247

1.64

17.77

1.7

1.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

308

1807

1.72

17.75

3.2

3.4

1.15

1.57

1.85

264

1634

(3020961) Endomysium IgA Ab [Titer] in Serum

1004

7542

1.36

17.71

1.1

126.88

195.60

titre

0.68

226

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

757

5440

1.41

17.48

2.4

2.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

344

2094

1.66

17.28

1.2

278.04

319.04

titre

0.15

167

(3045424) Erythrocytes [Presence] in Urine

827

6057

1.39

17.09

2.1

0.03

0.14

estimate

0.44

276

2099

(3034770) Mitochondria Ab [Titer] in Serum

566

3876

1.48

16.93

1.3

811.54

1029.18

titre

0.18

110

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

644

4523

1.44

16.89

2.5

3.0

94.70

94.29

0.18

621

4376

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

477

3166

1.52

16.61

3.2

35.69

46.96

mg/l

1.22

393

2688

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

236

1311

1.81

16.46

1.3

1.2

62.80

40.73

u/ml

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

205

1090

1.89

16.42

1.2

1.3

1.77

1.99

mmol/l

4.86

189

1024

(3002079) Sodium [Moles/time] in 24 hour Urine

135

617

2.20

16.38

1.2

1.3

168.01

161.22

mmol/24h

0.36

135

617

(3034860) Kappa light chains.free [Mass/volume] in Serum

476

3169

1.52

16.34

3.2

48.07

66.97

mg/l

0.55

391

2688

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

164

809

2.04

16.32

2.7

3.2

85.74

140.28

nmol/l

1.13

157

802

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

190

991

1.93

16.14

18.1

15.7

5965.22

2113.92

nmol/l

0.32

184

962

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

129

583

2.22

16.09

1.0

1.43

0.84

u/ml

0.65

123

574

(3023410) Appearance of Cerebral spinal fluid

260

1497

1.75

16.07

1.4

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2634

22501

1.21

16.06

2.0

1.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

432

2828

1.54

16.04

2.9

3.1

3.21

2.82

ratio

0.14

213

1609

(3021661) Pineapple IgE Ab [Units/volume] in Serum

14.46

15.79

1.0

0.23

0.03

u/ml

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

195

1036

1.89

15.69

23.1

21.5

12846.02

2295.84

nmol/l

0.65

188

1004

(3017354) Segmented neutrophils/Leukocytes in Blood

212

1158

1.84

15.64

3.0

3.4

56.85

56.33

0.13

175

1002

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

12.88

15.61

1.0

3.68

0.66

u/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

362

2293

1.59

15.53

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

340

2127

1.61

15.37

1.7

1.5

—

(3036180) Methadone [Presence] in Urine

6.98

15.24

2.3

2.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

284

1705

1.68

15.11

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

414

2732

1.53

14.85

1.8

1.6

12965.20

13328.04

e6/l

0.05

269

1920

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

398

2605

1.54

14.82

1.7

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

370

2386

1.56

14.72

1.9

2.1

2.67

10.77

titre

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

370

2394

1.56

14.51

1.3

4.81

3.41

u/ml

0.33

154

892

(3044242) Glucose [Moles/volume] in Arterial blood

118

539

2.20

14.40

2.8

2.0

7.44

7.92

mmol/l

0.86

118

539

(3004616) Nuclear Ab [Presence] in Serum

272

1636

1.67

14.39

1.4

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

229

1315

1.75

14.34

1.2

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

359

2314

1.57

14.33

1.5

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

133

639

2.09

14.27

1.3

138.07

134.94

nmol/l

0.36

133

639

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

153

775

1.98

14.21

1.2

1.5

5.48

5.94

u/l

0.51

130

669

(3023419) Bacteria identified in Sputum by Culture

226

1298

1.75

14.15

2.5

2.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

362

2345

1.56

14.14

1.4

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

413

2761

1.51

13.96

1.2

1.1

18.06

15.33

au/ml

0.34

107

757

(3004716) Salmonella sp identified in Stool by Organism specific culture

990

7681

1.31

13.95

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

143

713

2.02

13.90

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

167

879

1.91

13.88

1.7

1.6

21.37

22.84

umol/l

0.28

152

820

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

673

2.05

13.87

1.5

1.4

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

17.52

13.80

1.1

1.0

1.40

0.07

u/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

424

2858

1.50

13.78

5.9

6.0

709.42

1252.82

iu/ml

0.35

374

(3039162) Centromere protein B Ab [Units/volume] in Serum

288

1779

1.63

13.76

1.3

31.61

56.30

u/ml

0.59

113

(21491868) Cryoglobulin [Mass/volume] in Serum

104

460

2.27

13.74

1.2

0.15

0.21

g/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

337

2164

1.57

13.69

1.1

3.22

2.70

0.36

396

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

130

633

2.06

13.49

1.1

10.48

10.70

u/ml

0.02

119

(3023323) Follitropin [Units/volume] in Serum or Plasma

1225

9811

1.27

13.48

1.4

21.71

23.72

iu/l

1.51

1037

8331

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

652

4781

1.38

13.41

1.7

1.6

1.93

6.42

iu/ml

0.51

111

851

(3040151) Glucose [Moles/volume] in Capillary blood

223

1300

1.73

13.28

11.8

9.9

7.68

7.26

mmol/l

0.29

195

1089

(3017315) Amylase [Enzymatic activity/volume] in Urine

129

631

2.05

13.24

1.5

1.2

310.22

282.85

u/l

0.15

118

576

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

125

606

2.07

13.14

1.5

—

(3008295) Osmolality of Serum or Plasma

221

1291

1.72

13.07

1.6

1.5

277.77

280.88

mosm/kgh2o

1.13

160

991

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

229

1351

1.71

13.07

2.2

2.7

23.20

20.52

nmol/l

2.11

215

1292

(3038026) Centromere Ab [Units/volume] in Serum

173

940

1.85

13.06

1.3

1.2

83.73

48.57

u/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

355

2336

1.53

12.96

1.3

4.58

4.03

u/ml

0.16

171

1083

(3049717) Cytology report of Urine Cyto stain

475

3317

1.45

12.92

2.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

145

749

1.95

12.78

2.2

2.05

1.87

umol/l

1.74

136

697

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

129

640

2.02

12.75

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

196

1120

1.76

12.55

1.2

188.00

202.26

titre

0.07

186

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

298

1900

1.58

12.53

1.1

1.47

1.49

g/l

0.41

284

1750

(3003694) ABO and Rh group [Type] in Blood

4567

41493

1.15

12.45

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

177

988

1.80

12.28

3.0

2.7

22.38

27.05

mg/l

1.09

127

700

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

191

1092

1.76

12.22

1.3

1.2

64.25

70.30

u/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

338

2231

1.53

12.19

3.6

3.4

302.06

1498.30

u/ml

1.73

110

(3006442) Creatine [Moles/volume] in Serum or Plasma

151

805

1.88

12.14

1.5

1.4

72.45

79.17

umol/l

2.67

151

805

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

308

1995

1.56

12.10

1.7

1.8

1584.00

2232.20

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

181

1022

1.78

12.09

1.3

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

211

1245

1.70

12.07

2.9

3.4

4.77

9.09

nmol/l

0.47

201

1205

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

121

599

2.03

12.06

2.3

2.4

140.14

152.84

nmol/l

0.69

109

529

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

204

1193

1.72

12.06

1.6

1.4

1.59

1.46

nmol/l

0.88

181

1065

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

167

923

1.82

11.98

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

167

923

1.82

11.98

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

167

923

1.82

11.98

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

556

4051

1.39

11.92

1.9

2.1

3.18

6.80

iu/l

1.02

214

1796

(3039000) Anion gap in Blood by calculation

329

2170

1.53

11.92

6.6

7.0

11.80

11.28

mmol/l

1.61

304

1936

(3018572) Chloride [Moles/volume] in Blood

329

2171

1.53

11.89

6.6

7.1

104.42

105.26

mmol/l

2.21

304

1938

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

179

1014

1.77

11.84

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

172

967

1.79

11.68

3.8

4.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

245

2.62

11.63

1.3

1.4

1.18

mmol/l

0.21

245

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

449

2.17

11.55

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

338

2268

1.50

11.31

1.9

1.6

455.73

367.46

mu/l

1.32

278

1844

(3034274) Bile acid [Moles/volume] in Serum --fasting

422

2958

1.44

11.30

2.2

2.4

7.59

6.46

umol/l

0.45

313

2175

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

346

2338

1.49

11.19

1.5

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

457

3256

1.42

11.19

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

355

2418

1.48

11.05

2.6

2.4

0.96

0.84

nmol/l

1.44

297

2070

(3003129) Base excess in Capillary blood by calculation

205

1234

1.67

10.94

2.4

2.2

0.84

0.56

mmol/l

0.52

191

1174

(1002224) Polysomnography panel

900

7137

1.28

10.74

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

225

1394

1.62

10.73

1.2

26.33

33.03

nmol/l

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

211

1295

1.64

10.46

1.2

33.52

40.83

mg/l

2.77

172

1090

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

323

2186

1.49

10.40

1.1

120.14

115.48

1.97

293

1997

(3026389) Candida sp identified in Specimen by Organism specific culture

308

2065

1.50

10.39

1.3

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

206

1260

1.64

10.36

1.1

222.27

243.48

mg/l

1.21

178

1127

(3033923) Metanephrine [Moles/time] in 24 hour Urine

213

2.64

10.35

1.1

0.66

0.71

umol/24h

0.37

100

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

303

2029

1.50

10.28

1.2

1.30

1.08

0.22

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

449

3240

1.40

10.25

1.5

8.33

25.05

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

334

2283

1.47

10.24

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

257

1663

1.55

10.22

1.2

1.1

97.62

96.28

0.32

242

1569

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

160

918

1.75

10.20

2.2

2.6

98.58

98.30

0.03

151

858

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5517

51222

1.12

10.09

2.0

1.9

1.45

1.36

mmol/l

10.71

4735

44289

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

195

1190

1.65

9.92

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

121

644

1.89

9.87

1.1

—

(21494755) Public health laboratory ask at order entry panel

1351

16038

0.83

9.84

1.3

—

(3017569) Oxygen content in Arterial blood

102

513

2.00

9.83

2.7

2.3

15.85

16.10

0.28

102

513

(3010838) Calcium [Moles/time] in 24 hour Urine

315

2148

1.48

9.80

1.8

2.0

4.89

5.20

mmol/24h

0.91

285

1947

(44790047) Parainfluenza type 1 nucleic acid detection

246

1595

1.55

9.72

1.7

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

246

1595

1.55

9.72

1.7

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

246

1595

1.55

9.72

1.7

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

246

1595

1.55

9.72

1.7

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

103

522

1.98

9.72

1.4

86.74

207.19

nmol/24h

1.21

103

522

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

4.17

9.61

1.1

289.95

66.43

u/l

0.41

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

138

774

1.79

9.54

1.8

1.9

132.27

137.20

0.32

131

730

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

456

6151

0.73

9.53

1.1

0.62

ratio

0.02

635

(4027681) Cerebrospinal fluid IgG ratio and IgG index

168

997

1.69

9.52

1.3

1.2

0.60

0.65

ratio

0.48

578

(1761482) Bacteria [#/volume] in Urine by Culture

328

2270

1.45

9.47

4.1

3.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

185

1128

1.65

9.46

1.1

283.76

287.96

mg/l

0.33

173

1034

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

175

1059

1.66

9.23

1.9

2.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

715

5628

1.28

9.09

1.5

1.4

9.23

9.37

u/l

0.10

579

4506

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

107

563

1.91

9.08

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

107

563

1.91

9.08

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

107

563

1.91

9.08

1.8

1.9

—

(3017509) Phencyclidine [Presence] in Urine

228

2.46

9.06

2.7

1.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

500

6600

0.75

9.04

1.1

0.86

0.88

g/l

1.12

494

6588

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

107

564

1.90

9.03

1.8

1.9

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.01

8.99

1.0

1.3

—

mmol/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

414

3016

1.38

8.98

1.6

1.5

154.79

144.00

au/ml

1.06

117

859

(3009883) Potato IgE Ab [Units/volume] in Serum

7.92

8.82

1.1

1.0

0.31

0.12

u/ml

0.65

(21494815) CD4 cells/Lymphocytes in Specimen

195

1232

1.59

8.68

2.1

2.6

42.01

39.87

1.31

189

1215

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

233

2.41

8.66

1.1

—

(4268621) Lupus anticoagulant assay

255

1711

1.50

8.65

2.4

2.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1545

13255

1.19

8.62

4.6

4.4

31.29

32.13

2.45

1158

9359

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

762

1.75

8.60

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

187

1174

1.60

8.55

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

814

6564

1.25

8.48

1.4

1.3

219.90

227.49

miu/ml

0.24

357

3153

(3011412) CD3 cells [#/volume] in Blood

210

1361

1.55

8.39

2.2

2.7

1369.74

1249.18

e6/l

1.10

176

1150

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

131

754

1.74

8.35

1.1

1.32

8.18

nmol/l

1.88

143

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1125

9408

1.21

8.31

3.0

2.6

70.74

72.04

ml/min/173m2

0.45

458

3892

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

457

1.95

8.16

4.1

4.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

135

2.82

8.08

1.6

1.5

118.50

118.99

ug/l

0.01

117

(3016038) Potassium [Moles/volume] in Urine

127

732

1.74

8.07

1.8

1.4

33.19

34.90

mmol/l

0.34

107

654

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

688

1.76

8.06

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

11392

110799

1.13

8.05

25.3

17.4

332.65

332.97

g/l

3.32

11358

110189

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

306

2.16

7.97

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

530

4087

1.31

7.92

1.1

5.56

5.74

eliau/ml

0.04

590

(3037121) Protein [Mass/volume] in Urine

528

4077

1.31

7.82

3.6

3.4

568.93

415.49

mg/l

0.22

256

1932

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.47

7.79

2.2

1.6

44.35

44.63

umol/l

0.01

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

102

558

1.83

7.74

1.9

145.08

157.90

0.81

528

(1175426) CD3 cells/Lymphocytes in Blood

177

1128

1.58

7.65

2.0

2.4

74.42

73.65

0.33

171

1089

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.42

7.64

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

124

723

1.72

7.60

1.5

35.73

21.63

u/ml

0.67

133

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

114

650

1.76

7.56

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

437

3305

1.33

7.52

1.2

1.1

—

(4195642) Thrombophilia screening test

307

2196

1.41

7.50

1.2

—

(3045142) Bone marrow Pathology biopsy report

182

1174

1.56

7.48

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1276

10903

1.19

7.46

2.5

2.3

11.98

12.62

nmol/l

1.62

1152

9961

(3037756) Immunofixation for Serum or Plasma

273

1915

1.43

7.44

1.9

1.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

179

1152

1.56

7.43

2.9

3.3

26.22

25.31

mu/l

0.11

169

1093

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

369

2.01

7.42

1.4

1.3

109.04

121.37

nmol/l

0.34

273

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

115

662

1.74

7.39

2.4

2.2

27.50

28.00

umol/l

0.25

109

627

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1218

10387

1.19

7.28

4.1

4.3

17.78

25.42

ug/l

0.41

964

8184

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

194

1278

1.52

7.26

2.2

2.0

23.47

25.34

mg/l

0.20

468

(3002523) Influenza virus A Ag [Presence] in Specimen

435

3306

1.33

7.25

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

200

1330

1.51

7.17

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

409

1.94

7.13

1.5

1.3

16.75

16.62

umol/l

0.06

354

(3000093) Morphology [Interpretation] in Blood Narrative

166

1061

1.57

7.12

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

100

559

1.79

7.11

2.2

2.9

1.02

1.26

ug/l

0.62

528

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

164

2.50

6.97

1.1

1.3

31.02

43.56

mg/l

1.39

139

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

115

675

1.71

6.92

1.5

1.4

72.92

72.93

0.00

110

646

(3012920) Ethanol [Mass/volume] in Serum or Plasma

6.30

6.92

1.0

1.4

1.82

1.99

g/l

0.21

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

108

623

1.74

6.92

1.4

1.3

28.33

62.34

titre

—

(3016330) Potassium [Moles/time] in 24 hour Urine

183

2.41

6.89

1.1

1.3

—

96.20

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

174

1134

1.54

6.87

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

191

1271

1.51

6.85

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

102

581

1.76

6.83

1.1

—

0.13

—

(37208534) Antinuclear antibody arbitrary concentration in serum

466

1.85

6.79

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

466

1.85

6.79

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

459

1.86

6.78

2.8

2.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

110

642

1.72

6.77

1.4

1.3

134.00

516.43

titre

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

151

961

1.58

6.63

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

181

1200

1.51

6.62

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

112

662

1.70

6.59

1.5

1.4

599.33

495.64

mu/l

0.51

107

633

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

509

1.79

6.50

1.1

1.2

95.17

92.77

0.23

234

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

177

1174

1.51

6.47

1.1

6.47

7.96

iu/ml

0.34

314

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

229

1601

1.44

6.42

1.2

1.1

1.71

1.72

iu/ml

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

189

1274

1.49

6.40

1.6

56.67

55.30

0.16

112

801

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

521

4129

1.27

6.37

5.3

5.2

1.46

1.39

mg/l

1.32

482

3850

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

104

609

1.71

6.35

1.3

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

167

1100

1.52

6.32

1.2

105.19

114.01

pmol/l

1.49

167

1100

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

523

1.76

6.24

1.1

94.15

92.86

0.17

234

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

728

1.64

6.18

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.05

6.17

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

173

1160

1.50

6.04

1.3

73.12

79.86

0.41

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

193

1326

1.46

5.97

1.2

—

(3000012) Reticulocyte production index

198

1369

1.45

5.93

2.5

2.1

0.90

0.05

129

894

(40761539) Cells [Type] in Urine sediment by Light microscopy

262

2.06

5.91

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

328

2473

1.33

5.86

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

389

1.85

5.80

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

144

941

1.54

5.70

2.2

2.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

115

717

1.61

5.58

1.4

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

141

922

1.53

5.57

2.2

2.9

0.86

0.73

e9/l

1.56

133

892

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

453

1.77

5.55

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

483

1.74

5.53

1.3

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

537

1.70

5.47

1.2

115.27

108.64

0.95

487

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

303

2284

1.33

5.46

1.1

80.30

5184.27

iu/ml

0.64

524

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1624

18175

0.88

5.45

1.8

3.51

3.48

ratio

0.31

1196

13498

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

111

692

1.61

5.40

1.3

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

136

2.43

5.35

1.3

1.8

0.81

2.06

mg/l

1.90

100

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

109

679

1.61

5.33

1.3

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

137

2.41

5.27

2.2

3.8

43.38

41.77

umol/l

0.12

117

(3013247) Albumin in CSF/Albumin in Serum or Plasma

366

1.83

5.25

1.1

5.69

6.38

mg/g

0.60

353

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

177

1231

1.44

5.20

1.6

1.8

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

3.83

4.32

mg/l

0.16

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

3.07

1.85

mg/l

0.41

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

1.25

2.24

mg/l

1.08

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

1.20

1.73

mg/l

0.67

103

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

1.30

1.25

mg/l

0.02

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

0.21

0.99

mg/l

3.42

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

0.54

2.60

mg/l

3.88

101

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

1.44

1.80

mg/l

0.26

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

132

2.43

5.18

1.3

1.8

1.72

3.08

mg/l

0.96

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

434

1.75

5.16

1.2

1.3

33.00

17.20

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

177

2.21

5.10

2.0

1.9

—

(3010503) CD19 cells [#/volume] in Blood

118

758

1.56

5.09

2.6

2.7

208.52

216.62

e6/l

0.04

112

738

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

146

2.33

5.06

7.8

11.2

5.75

5.61

mmol/l

0.11

146

(3025018) Bordetella pertussis Ab [Titer] in Serum

164

1131

1.45

5.05

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

154

1050

1.47

5.03

2.1

2.9

225.78

217.85

e6/l

0.21

122

850

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

128

2.42

5.02

1.4

1.3

0.33

0.57

iu/ml

0.92

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

195

1393

1.41

4.96

1.3

1.4

—

titre

—

(3051611) Lipemic interference index of Serum or Plasma

160

1103

1.46

4.94

3.6

3.3

14.80

13.87

index

0.40

689

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

150

1022

1.47

4.92

2.1

2.8

568.27

523.25

e6/l

0.54

113

793

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

204

1473

1.39

4.88

1.3

1.5

8.23

7.93

mmol/l

0.49

196

1422

(3004451) EKG impression Narrative

532

1.66

4.88

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

144

976

1.48

4.86

1.6

31.29

32.42

0.13

585

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

352

2756

1.28

4.85

1.4

20.15

23.64

u/l

1.35

295

2273

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

340

1.83

4.83

1.2

80.62

74.06

0.33

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

235

2.00

4.82

1.4

1.2

—

(3012441) Differential panel - Pleural fluid

137

921

1.49

4.82

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

101

2.58

4.78

1.1

1.79

1.71

umol/24h

0.16

101

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

497

1.67

4.78

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

497

1.67

4.78

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

298

2289

1.31

4.76

1.1

3.88

3.06

eliau/ml

0.44

117

1159

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.57

4.75

1.1

0.22

0.20

g/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

387

3078

1.26

4.71

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

464

3772

1.24

4.66

3.6

3.7

1046.90

2107.54

u/ml

0.55

405

3261

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1225

13808

0.88

4.59

1.6

3.40

3.47

mmol/l

1.21

805

9163

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

325

1.82

4.56

1.6

10.34

8.98

ug/l

1.07

325

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

247

1.95

4.56

1.1

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

578

4817

1.21

4.56

1.9

1.8

37.02

40.80

nmol/l

3.14

566

4725

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

160

2.19

4.54

1.3

2.35

1.53

iu/ml

1.47

(3028308) Erythrocytes [#/volume] in Pleural fluid

137

935

1.47

4.50

1.5

1.4

38627.73

55314.24

e6/l

0.46

506

(3042111) Morphology [Interpretation] in Bone marrow Narrative

221

1647

1.35

4.39

1.6

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

173

1240

1.40

4.37

1.2

1.1

13.08

18.81

u/ml

2.11

529

(3042733) HLA Ab [Presence] in Serum

458

1.66

4.32

4.2

4.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

166

1185

1.41

4.30

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

505

1.63

4.28

2.3

2.2

29.49

31.21

0.49

505

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

253

1.90

4.27

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

166

1187

1.40

4.26

1.4

1.3

4.78

5.77

umol/l

2.72

143

1063

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

341

1.76

4.21

1.3

1.2

100.58

83.55

1.02

(3050129) First trimester maternal screen panel - Serum or Plasma

674

7882

0.85

4.19

1.5

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

3.26

4.18

1.1

1.0

4.36

0.37

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

137

951

1.44

4.16

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

271

2098

1.30

4.14

3.1

3.8

293.82

635.08

u/ml

1.16

242

1910

(3023199) Leukocytes [#/volume] in Pleural fluid

151

1068

1.42

4.14

1.5

1.4

2686.65

3378.41

e6/l

0.26

101

733

(3012565) Volume of 24 hour Urine

574

1.57

4.09

2.1

2154.09

1995.14

0.58

528

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

134

930

1.44

4.08

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

309

2440

1.27

4.05

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

101

664

1.52

4.02

1.6

1.8

1.14

1.30

nmol/l

0.80

501

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

163

1176

1.39

4.00

1.6

2.2

21.15

24.17

ug/l

0.53

157

1157

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

112

754

1.49

3.99

1.6

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

107

714

1.50

3.98

1.5

1.7

5.47

4.35

nmol/l

0.18

581

(40768446) Kidney Pathology biopsy report

547

1.58

3.97

1.9

1.7

—

(3042631) Mycobacterium sp identified in Specimen

173

1265

1.37

3.92

2.9

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

104

696

1.50

3.83

1.2

11.94

14.90

u/ml

0.10

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

397

1.67

3.82

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

397

1.67

3.82

2.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.06

3.80

1.0

5.65

3.20

u/ml

0.20

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

570

1.55

3.77

1.6

1.60

2.89

u/field

1.58

407

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

153

2.09

3.76

2.3

2.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

407

1.65

3.74

2.4

3.0

28.83

28.51

umol/l

0.08

299

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.91

3.73

1.1

1.0

0.78

0.64

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

295

1.77

3.72

1.2

1.1

—

34.93

u/ml

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.45

3.70

1.5

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

357

2903

1.24

3.67

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

403

1.64

3.63

2.1

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

174

1294

1.35

3.58

3.0

2.5

1.21

1.43

g/24h

0.71

111

758

(43055514) Macroprolactin [Presence] in Serum or Plasma

514

1.56

3.57

1.5

1.3

—

(3020491) Glucose [Moles/volume] in Blood

129

914

1.41

3.56

1.6

1.8

6.65

6.25

mmol/l

0.77

692

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

694

1.47

3.50

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

151

2.05

3.50

1.1

230.00

317.56

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

301

1.73

3.49

1.8

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

112

2.23

3.47

2.7

3.4

1.45

1.32

mg/l

0.09

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

411

3417

1.21

3.42

2.1

1.9

198.52

197.71

pmol/l

0.04

388

3263

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

246

1935

1.28

3.40

2.4

2.6

19.34

27.32

iu/ml

1.05

147

(3034891) Synovial lining cells/cells in Synovial fluid

521

1.54

3.39

1.6

1.5

5.38

4.09

—

116

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

474

1.56

3.37

2.3

2.0

35.93

143.96

ug/min

1.28

111

(3003434) Protein [Mass/volume] in Pleural fluid

163

1213

1.35

3.37

1.5

1.4

33.19

33.43

g/l

0.08

147

1098

(4035726) Immunohistochemistry procedure

1092

9795

1.12

3.35

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.72

3.33

1.0

0.38

0.06

u/ml

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

101

694

1.46

3.32

1.2

1.3

58.00

72.00

—

(3044927) Protein electrophoresis panel - Urine

125

895

1.40

3.28

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

463

1.56

3.24

1.2

1.1

8.40

5.88

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

121

866

1.40

3.20

1.1

1.10

u/l

0.02

349

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

102

708

1.44

3.19

1.3

1.2

28.14

22.01

u/l

0.26

590

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

127

917

1.39

3.19

1.1

1.2

1.09

1.06

ratio

1.74

108

765

(40759632) Porphyrins [Mass/mass] in Stool

6.37

3.18

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

144

1063

1.36

3.16

1.4

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

199

1540

1.30

3.15

3.3

3.2

0.86

0.81

nmol/l

0.96

156

1222

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

207

1.84

3.15

1.4

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

802

1.41

3.14

1.9

1.86

1.58

u/field

0.26

448

(3045788) Cell count panel - Pleural fluid

122

878

1.39

3.13

1.6

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

113

803

1.41

3.12

1.7

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

548

1.50

3.11

2.5

2.3

15.94

56.54

umol/l

4.12

(3026250) Tacrolimus [Mass/volume] in Blood

663

1.45

3.10

50.3

41.8

7.16

7.24

ug/l

0.18

612

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

125

2.08

3.07

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

329

1.64

3.05

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

329

1.64

3.05

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

329

1.64

3.05

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

329

1.64

3.05

1.1

—

(3024316) Viscosity of Plasma

2.58

3.03

3.3

1.5

1.55

1.61

mpas

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

104

733

1.42

3.02

1.3

1.2

87.33

89.94

u/l

0.07

626

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

286

2325

1.23

3.02

2.5

2.4

133.69

110.93

ug/min

0.33

167

1460

(3010144) Erythrocytes [#/volume] in Synovial fluid

136

1004

1.36

3.00

1.4

161798.91

97639.31

e6/l

0.44

681

(3024263) Appearance of Synovial fluid

561

1.48

3.00

1.4

1.8

—

(3004775) Volume in Urine collected for unspecified duration

105

743

1.42

2.99

2.4

2.3

720.16

638.58

0.61

534

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.55

2.98

1.2

1.1

25.26

34.26

umol/24h

0.84

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

490

1.51

2.95

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

190

1.84

2.95

1.2

65.00

62.89

ug/l

0.24

190

(3016750) Collection duration of Urine

556

1.48

2.93

2.3

2.2

517.68

500.61

min

0.76

437

(3000060) B lymphocytes [#/volume] in Blood

550

1.48

2.88

1.8

2.7

0.22

0.28

e9/l

0.61

254

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

136

1012

1.35

2.87

1.3

1.4

11.20

11.80

umol/l

0.64

127

957

(3035153) Lemon IgE Ab [Units/volume] in Serum

6.67

2.86

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

510

1.49

2.86

1.2

1.1

—

(3014271) Vancomycin [Susceptibility]

385

1.56

2.78

2.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

114

830

1.38

2.78

1.5

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

598

1.44

2.72

2.3

8.60

9.43

mg/l

0.74

503

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

357

1.57

2.68

1.0

1.1

16.07

36.10

iu/ml

4.96

357

(40768806) Pleura Pathology biopsy report

124

921

1.35

2.68

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

593

1.44

2.65

1.7

2686.32

2699.09

titre

0.01

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

560

1.45

2.65

1.1

44.72

319.98

ng/l

1.25

155

(3020393) Adenovirus Ag [Presence] in Stool

205

1.76

2.64

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

5222

54077

0.95

2.62

2.9

2.8

—

(3036048) Francisella tularensis Ab [Titer] in Serum

321

1.59

2.58

1.2

1.1

—

373.33

—

(3024869) Neuronal Ab [Presence] in Serum

185

1.79

2.55

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2921

27718

1.07

2.54

4.9

2.31

2.59

ug/l

0.44

2624

25304

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

674

1.40

2.54

2.2

2.0

208.65

194.07

u/l

0.58

667

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.16

2.50

1.4

1.6

—

(44806420) Estimation of glomerular filtration rate

198

1584

1.25

2.48

2.4

2.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

247

1.66

2.48

2.4

2.5

1.47

1.46

mmol/l

0.01

176

(3014891) Appearance of Pleural fluid

102

2.06

2.46

1.5

—

(4015189) Microbial culture of sputum

225

1.69

2.45

2.0

2.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

311

1.58

2.42

1.3

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

921

0.68

2.41

1.6

1.5

0.55

0.52

e9/l

0.50

921

(3025130) Human papilloma virus identified in Specimen

321

2707

1.19

2.41

1.7

1.9

—

(40768441) Liver Pathology biopsy report

126

956

1.32

2.40

1.4

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

167

1.80

2.39

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

336

1.55

2.38

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

336

1.55

2.38

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

336

1.55

2.38

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

116

873

1.33

2.34

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

183

1.75

2.34

1.2

1.6

107.67

62.16

ng/l

0.48

113

(3002619) Bacteria identified in Specimen by Culture

322

1.55

2.33

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

131

1004

1.31

2.33

2.6

2.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

214

1.68

2.31

1.3

29.50

102.46

titre

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

112

1.97

2.29

1.0

1.2

55.47

43.63

mg/l

—

(4034850) Laboratory test

408

3528

1.16

2.27

9.4

8.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

563

1.41

2.25

2.0

5.2

2612.98

1089.41

mg/l

0.25

411

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

580

1.40

2.25

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.15

2.24

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

725

1.35

2.23

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

194

1.70

2.21

1.8

1.9

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

100

744

1.35

2.20

2.3

2.8

43.23

42.04

0.30

399

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.50

2.18

1.2

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.24

2.17

1.2

2.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

628

1.37

2.14

1.3

1.2

14.52

13.20

u/l

0.31

579

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

155

1230

1.26

2.14

1.2

64.80

66.71

u/l

0.11

129

1082

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.10

2.12

1.0

1.1

—

0.22

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

212

1.65

2.12

1.2

72.02

80.52

mg/l

0.04

149

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

620

5548

1.12

2.10

1.6

1.7

4.55

4.23

mg/l

0.33

480

4026

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

333

2862

1.17

2.05

1.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.32

2.04

1.2

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

101

763

1.33

2.04

1.2

1.3

812.50

1011.54

titre

0.77

156

(40768795) Lymph node Pathology biopsy report

149

1185

1.26

2.03

1.3

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

449

1.43

2.02

1.9

1.8

219.13

141.71

au/ml

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.08

2.01

3.4

1.4

4.87

2.40

mu/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.63

2.00

1.3

2.9

4.30

4.51

mmol/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.63

2.00

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.00

1.99

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

2.14

1.97

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

304

1.51

1.96

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

370

1.46

1.94

1.5

—

(3028433) Virus identified in Specimen by Culture

403

1.44

1.94

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

273

1.54

1.93

2.0

1.5

0.23

0.25

mmol/l

—

(3017704) Immunofixation for Urine

487

1.40

1.93

1.7

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

486

5467

0.89

1.92

1.4

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

355

1.47

1.91

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.92

1.89

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

243

1.57

1.88

1.2

328.52

320.20

pmol/l

0.04

178

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

423

1.42

1.87

2.9

2.7

0.63

0.61

mmol/l

1.62

423

(3033099) Centromere Ab [Titer] in Serum

316

1.49

1.87

1.1

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

2.86

1.86

1.0

1.1

—

371.20

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.08

1.85

1.1

1.3

0.22

0.76

umol/24h

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

501

1.38

1.83

1.1

51.49

60.06

u/ml

0.55

491

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

391

4441

0.88

1.82

1.5

55.89

60.50

ug/l

1.48

391

4441

(3008536) Aspergillus sp Ab [Presence] in Serum

230

1.57

1.80

2.0

2.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

246

1.55

1.80

1.1

1.0

15.19

7.54

u/ml

0.34

246

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.79

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

508

5670

0.89

1.79

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

153

1.70

1.79

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

328

1.46

1.77

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

184

1.63

1.77

1.1

—

(3006462) Nitrate [Presence] in Urine

547

1.35

1.77

2.5

2.9

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

112

880

1.27

1.74

1.9

1.8

3.09

3.74

mg/l

1.43

105

849

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.22

1.73

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

423

1.40

1.70

2.3

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

638

1.32

1.69

2.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.95

1.69

1.5

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

149

1.68

1.66

2.7

2.8

65.42

67.23

pmol/l

0.03

129

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

159

1309

1.22

1.65

4.2

5.2

51.22

88.33

u/ml

1.00

466

(3036782) Glucose [Moles/volume] in Pleural fluid

117

932

1.26

1.64

1.3

7.06

6.22

mmol/l

1.98

105

866

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

301

1.46

1.64

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

142

1.69

1.64

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

471

1.36

1.60

1.1

—

(3024932) HLA-DR beta [Type]

420

1.38

1.60

1.1

—

(3034614) HLA Ag [Interpretation]

2.50

1.59

1.1

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.00

1.58

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.69

1.58

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.69

1.58

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

106

840

1.26

1.57

1.4

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.82

1.56

1.1

3.1

1.56

68.66

pmol/l

—

(3044009) aPTT.lupus sensitive (LA screen)

129

1.71

1.56

1.1

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

107

1.78

1.54

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.86

1.50

1.0

1.1

—

(3024471) HLA-A [Type]

427

1.36

1.47

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

147

1.63

1.46

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

326

1.41

1.46

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

148

1.62

1.43

2.8

2.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

269

1.45

1.43

1.4

1.2

15.12

11.48

pmol/l

0.31

104

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

229

1.49

1.40

3.1

2.8

72.19

29.98

mg/l

0.73

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

103

1.75

1.40

1.2

1.1

21.15

23.11

u/l

0.15

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.17

1.39

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

615

1.29

1.38

2.5

45.83

51.01

umol/l

0.70

557

(3020650) Glucose [Presence] in Urine

494

1.32

1.36

1.6

0.00

0.04

estimate

1.85

494

(3049233) Organic acids panel - Urine

2.13

1.33

1.1

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

367

1.36

1.32

1.4

1.6

14.18

5.61

nmol/l

0.49

356

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

121

1.65

1.30

1.1

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

217

1.48

1.30

1.7

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

292

1.41

1.29

1.1

1.2

39.95

39.56

g/l

0.05

150

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

153

1.57

1.28

1.2

1.1

—

(21494434) Karyotype in Bone marrow

110

901

1.22

1.27

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

344

1.37

1.27

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.00

1.27

8.4

7.1

—

(40762814) Titanium [Mass/volume] in Blood

122

1.64

1.27

3.0

2.5

2.69

4.30

ug/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

771

7175

1.08

1.26

2.8

3.2

36.81

49.11

u/ml

1.47

745

6942

(3037692) Legionella sp identified in Specimen by Organism specific culture

353

1.36

1.26

1.7

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

353

1.36

1.26

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

460

5043

0.91

1.24

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.86

1.23

1.4

360.40

510.88

nmol/l

0.74

(40762887) Creatinine [Moles/volume] in Blood

1.86

1.23

1.3

1.5

—

(3006270) Folate [Moles/volume] in Blood

105

860

1.22

1.1

356.15

382.10

nmol/l

0.73

765

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.96

1.21

13.7

9.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.16

1.21

6.1

8.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

548

1.28

1.21

1.1

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

548

1.28

1.21

1.1

1.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

305

1.38

1.20

1.9

1.6

0.20

0.23

nmol/l

0.15

221

(4146454) Self-monitoring of blood glucose

121

1008

1.20

2.7

2.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

280

1.39

1.19

1.4

12.15

13.50

g/l

0.37

207

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

181

1.49

1.17

6.1

5.3

35.63

37.01

ug/min

0.05

126

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

181

1.49

1.17

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

471

5141

0.91

1.17

1.5

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1122

11851

0.94

1.16

1.5

1.6

948.14

1007.42

mu/l

1.50

931

10147

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

102

1.67

1.15

2.9

2.1

0.76

0.73

u/field

0.05

102

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

307

3420

0.90

1.15

1.3

—

(4211845) Urine protein measurement

597

1.26

1.15

2.5

2.8

—

(3001556) Androgen free Index in Serum or Plasma

216

1.44

1.13

1.3

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.75

1.12

1.9

2.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.33

1.12

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.33

1.12

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

2.00

1.12

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

215

1890

1.14

1.11

1.4

1.3

38.34

30.93

u/l

0.27

186

1645

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

388

1.32

1.11

3.0

3.3

1.78

1.90

ratio

0.26

356

(3010375) cycloSPORINE [Mass/volume] in Blood

592

1.25

1.10

27.5

28.8

131.51

117.90

ug/l

0.76

485

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

182

0.55

1.09

9.8

7.8

70.90

70.56

—

144

(3005033) Fetal Nuchal fold Thickness US

453

4933

0.92

1.09

1.5

1.26

0.05

320

3652

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.19

1.08

2.3

5.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

110

1310

0.84

1.07

1.7

1.4

37.28

35.15

nmol/l

0.23

102

1202

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

202

1.44

1.07

1.6

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

105

1.62

1.05

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.12

1.05

1.4

1.1

27.01

32.82

mg/24h

—

(3052592) Norovirus Ag [Presence] in Stool

186

1.45

1.05

1.2

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.83

1.02

3.0

5.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

876

0.81

1.01

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

163

1.47

1.01

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

273

1.36

1.00

2.0

1.6

0.36

0.43

ug/l

0.50

198

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

387

1.29

0.98

1.6

2.0

40.44

40.47

g/l

0.02

387

(36303858) Crystals [Presence] in Urine

2.17

0.98

1.4

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

116

1.55

0.96

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

118

1006

1.17

0.95

1.3

145.65

187.56

pmol/l

2.74

118

1006

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.69

0.95

5.8

4.8

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.89

0.94

1.1

1.3

—

(3019174) dRVVT (LA screen)

133

1.50

0.94

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

353

3233

1.09

0.92

1.6

1.5

0.44

0.41

nmol/l

0.11

253

2555

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

141

1620

0.87

0.92

1.4

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

607

1.22

0.91

2.8

2.9

192.96

127.10

au/ml

0.52

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

626

1.22

0.90

1.0

98.17

93.76

0.55

505

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.63

0.90

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

160

1405

1.14

0.89

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.69

0.88

4.3

3.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

239

1.34

0.83

1.1

1.2

34.87

290.10

ug/l

1.34

114

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

146

1.44

0.82

1.1

1.4

57.55

62.12

0.16

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1714

16567

1.04

0.80

3.0

0.67

0.74

ug/l

2.98

1066

9883

(3044007) Cell count panel - Peritoneal fluid

329

1.28

0.80

2.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

164

1.40

0.79

1.4

1.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

148

1.42

0.77

1.3

1.6

22.00

15.43

nmol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

108

935

1.16

0.77

3.0

2.9

42.56

61.29

mg/l

0.59

686

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

132

1.44

0.75

1.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

132

1.44

0.75

1.1

46.52

32.75

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

132

1.44

0.75

1.1

17.74

25.12

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

386

1.24

0.75

1.8

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

1.57

0.74

1.5

1.8

46.50

62.47

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.08

0.74

1.0

—

(3007733) Chloride [Moles/volume] in Urine

1.84

0.73

3.6

1.5

95.71

81.33

mmol/l

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

2.00

0.72

2.4

6.2

1165.60

642.60

e6/l

—

(3013762) Body weight Measured

1.80

0.72

1.4

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.80

0.72

1.1

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

176

1.36

0.72

3.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.67

0.72

1.5

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

672

1.18

0.71

3.6

3.9

8.03

8.67

mg/l

0.50

547

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.58

0.71

8.1

5.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

239

1.30

0.68

2.0

4.4

155.32

61.91

u/l

0.42

232

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

703

1.17

0.68

1.7

1.6

3.98

6.65

u/l

2.60

572

(3046861) Legionella sp Ag [Presence] in Urine

1.53

0.68

1.0

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

1.59

0.68

1.2

1.6

37.40

20.00

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.63

0.66

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

585

6163

0.95

0.65

1.4

1.5

1.15

1.16

ratio

0.03

348

3700

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

449

1.20

0.64

4.4

3.3

1.17

1.23

0.09

449

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2255

21997

1.03

0.64

4.0

4.1

21.65

21.93

0.30

951

9677

(3051101) Glucose [Moles/volume] in Cord blood

146

1.37

0.63

4.8

6.0

7.80

8.29

mmol/l

0.43

146

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

146

1.37

0.63

1.8

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

644

1.17

0.63

1.0

782.35

748.43

ng/l

0.30

460

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.49

0.63

1.0

1.1

8.23

11.98

u/l

0.47

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

130

1.38

0.61

2.6

3.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

647

1.16

0.60

1.0

42.89

40.77

ng/l

0.20

469

(3041184) Isoniazid [Presence] in Urine

0.00

0.60

0.0

2.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.57

0.60

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

224

2062

1.09

0.60

1.4

7.23

6.88

mmol/l

1.02

203

1854

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

127

1137

1.12

0.59

1.6

1.9

30.77

859.69

pmol/l

0.87

155

(37021550) Renin [Units/volume] in Plasma --upright

236

1.27

0.59

1.2

1.4

122.82

100.07

mu/l

0.11

185

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

148

1.35

0.59

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

263

1.26

0.59

1.2

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

589

6180

0.95

0.58

1.4

1.5

1.19

ratio

0.02

356

3744

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

589

6180

0.95

0.58

1.4

1.5

0.94

0.95

ratio

0.06

352

3717

(3038071) Oxygen [Partial pressure] in Mixed venous blood

273

1.25

0.57

9.0

6.8

6.33

5.36

kpa

1.11

273

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

641

1.16

0.57

1.0

308.85

312.72

ng/l

0.05

473

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

811

1.14

0.56

1.3

1.4

5.47

5.46

mmol/l

0.03

766

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

579

6066

0.95

0.55

1.4

1.5

—

(3035880) pH of Pleural fluid

458

1.18

0.55

1.3

7.40

0.04

309

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

178

1.29

0.52

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

545

0.84

0.52

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.50

0.51

1.7

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

736

0.87

0.51

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.38

0.50

1.9

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

297

1.21

0.50

1.1

1.4

47.17

53.23

0.36

247

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1281

12450

1.03

0.50

7.6

6.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

127

1.34

0.49

1.1

84.71

90.96

titre

0.13

127

(40768793) Breast Pathology biopsy report

329

3104

1.06

0.49

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

306

3244

0.94

0.47

1.3

3.44

3.61

ug/l

0.16

285

2985

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

319

1.19

0.45

1.1

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.60

0.45

1.4

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.40

0.45

1.0

—

(40757373) Influenza virus identified in Isolate

201

1.24

0.44

1.8

1.5

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

274

1.20

0.44

1.1

1.3

39.53

39.45

0.00

187

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

628

6520

0.96

0.43

1.5

59.54

62.03

ug/l

0.70

526

5505

(40765096) Chromosome analysis panel by Banding

330

1.18

0.43

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

334

3169

1.06

0.43

1.4

1.5

83.44

123.72

pmol/l

2.60

322

3086

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

166

1.27

0.43

2.0

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

166

1.27

0.43

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

782

1.11

0.43

5.9

7.4

24.74

74.62

ug/l

0.96

534

(3026726) Creatinine [Moles/volume] in Specimen

0.64

0.42

2.0

2.6

408.83

429.74

umol/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.56

0.42

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.43

0.41

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

158

1.27

0.41

2.4

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

379

1.16

0.41

2.0

2.2

1126.57

2989.12

e6/l

0.41

255

(40768800) Prostate Pathology biopsy report

144

1555

0.93

0.40

1.2

—

(3032641) Amino acids panel - Urine

1.47

0.40

1.2

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

2.40

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.38

0.38

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

201

1890

1.06

0.37

4.1

3.9

26.73

28.78

u/ml

0.17

192

1831

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.33

0.35

8.3

5.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

254

2411

1.05

0.35

4.4

3.2

22.05

26.43

mg/l

1.69

174

1630

(3020356) Listeria sp identified in Specimen by Organism specific culture

135

1.26

0.35

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

190

1.21

0.34

5.3

7.0

10.73

10.63

0.07

190

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

480

1.13

0.34

1.4

1.5

14.29

14.57

pmol/l

0.16

404

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.33

0.33

1.5

1.2

319.17

368.20

nmol/l

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

249

1.16

0.30

1.4

1.88

2.38

0.35

214

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.27

0.30

2.1

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

231

1.17

0.29

2.1

3.0

3.93

159.58

ug/l

0.68

231

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.25

0.29

2.7

2.0

233.29

259.92

ug/l

—

(40763590) HLA-DQ beta [Type]

1.25

0.29

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

157

1.21

0.29

1.7

1.5

—

(46236302) HLA-C [Type] by High resolution typing

1.23

0.29

1.0

—

(40760409) HLA-A [Type] by High resolution

1.23

0.29

1.0

—

(40760410) HLA-B [Type] by High resolution

1.23

0.29

1.0

—

(3013862) HLA-DP [Type]

1.23

0.29

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

139

1.22

0.29

2.8

3.5

11.22

6.98

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

139

1.22

0.29

1.4

19.80

11.07

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

403

1.12

0.27

1.8

1.7

—

136.91

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.23

0.27

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.28

0.26

1.2

1.3

0.17

0.16

umol/l

0.14

(40761995) Spermatozoa Progressive [#/volume] in Semen

499

0.90

0.26

3.6

3.4

43.73

44.80

0.13

499

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.25

0.25

5.8

1.8

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

498

0.90

0.25

7.1

6.7

8.18

8.75

0.37

498

(3006598) pH of Arterial cord blood

223

0.85

0.24

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

189

1.16

0.24

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

124

1.21

0.23

1.2

1.3

315.50

343.54

u/l

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

746

1.07

0.23

1.3

1.2

8.63

9.58

mm/h

0.40

746

(3005532) Lymphocytes/Leukocytes in Pleural fluid

304

1.12

0.22

1.5

1.4

42.96

64.37

2.52

252

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.25

0.22

1.0

1.1

11.62

10.54

mg/l

0.11

(3001019) Free T4 and TSH panel - Serum or Plasma

812

8276

0.98

0.22

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

219

1.14

0.22

1.0

84.93

75.22

ug/l

0.53

185

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

569

5559

1.02

0.22

1.6

1.5

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.24

0.20

1.7

1.5

361.73

313.46

umol/24h

0.22

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

164

1.16

0.20

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

326

1.10

0.20

2.2

1.9

17648.33

14687.87

e6/l

0.09

165

(3032352) Blasts [#/volume] in Cerebral spinal fluid

154

0.84

0.19

1.2

3.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.13

0.18

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.13

0.18

1.7

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.21

0.18

1.3

2.3

0.59

0.64

ug/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

204

1.13

0.18

2.0

2.2

7.41

7.45

mmol/l

0.02

113

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

175

1689

1.04

0.17

1.6

7.93

7.64

mmol/l

1.16

169

1627

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.79

0.15

2.2

3.6

—

0.00

estimate

—

(3034426) Prothrombin time (PT)

477

1.07

0.15

1.3

1.2

28.59

28.17

0.17

477

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.15

0.15

18.7

6.3

98.44

103.88

g/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

171

1767

0.97

0.15

1.6

—

(44806071) Cardiolipin IgM antibody measurement

226

1.11

0.15

1.0

1.1

—

(4212803) Bone marrow aspirate examination

0.80

0.14

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

285

0.91

0.14

1.2

—

(4281824) Cell count and differential, peritoneal fluid

135

1304

1.04

0.13

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

132

1.14

0.13

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

302

0.93

0.11

1.3

—

(40758358) Immune stain study

1.11

0.09

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

196

0.92

0.09

1.0

1.1

1.02

1.24

mom

1.11

196

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.11

0.09

3.8

4.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.78

0.08

1.0

1.3

273.40

1374.59

u/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

146

1.10

0.08

1.2

2.37

1.69

mmol/l

0.12

(3021162) Amylase [Enzymatic activity/volume] in Specimen

205

1.07

0.07

3.1

2.9

297.23

2480.26

u/l

1.91

187

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.07

0.07

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

471

1.04

0.07

2.3

2.2

1.43

2.54

ug/l

3.41

399

(4038314) Semen analysis, post vasectomy

147

1.09

0.07

1.2

—

(3001729) Color of Synovial fluid

0.83

0.07

1.0

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

111

0.90

0.06

1.1

1.2

5.34

5.52

mmol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

665

1.02

0.04

3.3

3.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

101

1.09

0.04

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

301

0.96

0.03

2.4

2.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

192

1.04

0.02

1.5

1.4

—

(40758292) HTLV I+II Ab panel - Serum

282

1.03

0.02

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

113

1.06

0.01

1.1

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

641

1.01

0.01

1.1

1.2

37.78

20.70

u/l

0.65

580

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

127

0.94

0.01

1.0

1.1

—

(4133840) Spirometry

362

1.02

0.01

1.2

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

173

1.04

0.01

1.2

1.34

1.64

mmol/l

0.44

107

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

656

0.99

0.00

8.2

6.7

405.45

5848.39

u/ml

0.55

125

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

127

1.02

0.00

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

254

0.98

0.00

1.5

1.9

2.02

3.27

ug/l

0.55

149

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

188

1.01

0.00

1.4

1.2

5.98

5.63

mmol/l

0.88

188

(3002331) Protein [Mass/volume] in Peritoneal fluid

237

1.01

0.00

1.4

19.02

25.61

g/l

1.50

179

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

402

0.99

0.00

2.2

2.4

130.18

114.36

ng/l

0.33

255

(3010937) Rubella virus Ab [Presence] in Serum

137

1.02

0.00

1.2

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

469

1.00

0.00

1.3

1.2

65.28

70.48

ug/l

0.20

469

(46235168) Fasting glucose [Moles/volume] in Blood

184

0.98

0.00

3.3

1.2

8.36

7.39

mmol/l

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

1.04

0.00

1.2

1.4

55.93

73.00

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

646

1.01

0.00

1.1

1.2

103.58

79.45

u/l

1.01

585

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

109

1.01

0.00

1.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.96

-0.00

1.4

1.1

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

-0.00

0.0

16.3

—

5.50

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

208.44

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

331.60

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.7

—

12.67

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.0

—

0.06

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

45.64

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

23.11

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.13

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

19.77

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.88

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES – Other and unspecified effects of external causes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other and unspecified effects of external causes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other and unspecified effects of external causes (ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints